Diamandis Laboratory Conference Abstracts

(If [poster] appears beside the title then the PDF contains the full poster as presented at the conference.)

Generated 2009.08.25 at 11:16h by PubMgr (Publications Manager) version 18.006(508)

2009

Chen Y, Yazdanpanah M, Wang Y, Hoffman B, Diamandis E, Wong P.
Direct measurement of serum free testosterone by ultralfiltration and liquid chromatography-isotope dilution tandem mass spectrometry [abstract]
Clinical Chemistry 2009 Jun;55(6):A178 [ISI 000266895401139]
Kulasingam V, Batruch I, Smith CR, Martz T, Jeffery DA, Buckler A, Rezai T, Lopez MF, Diamandis EP.
Multiplexing combined with immuno-mass spectrometry: An approach to simultaneous quantification of multiple analytes in biological fluids [abstract]
Clinical Chemistry 2009 Jun;55(6):A204 [ISI 000266895401219]
Schnabl KL, Yazdanpanah M, Wong PY, Diamandis E, Cole D, Vieth R.
Isotope-Dilution, Liquid Chromatography-Tandem Mass Spectrometry Assay for Analysis of 24, 25(OH)(2)vitamin D-3 and 25(OH) Metabolites of Vitamins D-2 and D3 in Human Serum [abstract]
Clinical Chemistry 2009 Jun;55(6):A232 [ISI 000266895401300]
Barak V, Sherman Y, Doviner V, Edelman D, Diamandis EP.
New Kallikrein markers for ovarian cancers [abstract]
Biomedicine & Pharmacotherapy 2009 Jun;63(5):26 [ISI 000266901900027]
Eissa A, Diamandis E.
Characterization of human kallikrein-8, a keratinocyte-specific protease implicated in epidermis physiology and pathobiology [abstract]
Journal of Investigative Dermatology 2009 Apr;129:473 [ISI 000264994000471]
Shaw JLV, Petraki C, Watson C, Bricking A, Diamandis EP.
Localization of Human Tissue Kallikrein-Related Peptidases in Pregnancy-Associated Tissues [abstract]
Reproductive Sciences 2009 Mar;16(3):796 [ISI 000263609801258]

2008

Petraki C, Scorilas A, Komborozos V, Veloudis G, Michalopoulou F, Sfikas C, Papanastasiou P, Diamandis EP.
Immunohistochemical evaluation and prognostic significance of human tissue kallikrein 6 in colorectal cancer [abstract]
Histopathology 2008 Oct;53:357 [ISI 000259524800358]
Petraki C, Scorilas A, Veloudis G, Komborozos V, Evangelou I, Papanastasiou P, Sfikas C, Diamandis EP.
The immunohistochemical expression of human tissue kallikrein 10 is an independent predictor for disease outcome in patients with colorectal cancer [abstract]
Histopathology 2008 Oct;53:358 [ISI 000259524800359]
Chen Y, Yazdanpanah M, Hoffman B, Diamandis EP, Wong PY.
Detection of SERUM testosterone by liquid chromatography-isotope dilution tandem mass spectrometry [abstract]
Clinical Biochemistry 2008 Oct;41(14 to 15):109 [ISI 000260486900033]
Klem R, Saunders R, Sanders R, Adams T, Mcdermed JE, Sarno M, Diamandis E.
Total PSA (tPSA) level post-prostatectomy (RP) monitored with the NADIA (R) ultrasensitive PSA assay can predict the risk for biochemical recurrence (BCR) [abstract]
Clinical Chemistry 2008 Jun;54(6):C117 [ISI 000256325700420]
Klem R, Saunders R, Sanders R, Adams T, Mcdermed JE, Sarno M, Diamandis E.
Evaluation of post-prostatectorny (RP) total PSA (tPSA) levels using the NADIA (R) (Nucleic acid detection ImmunoAssay) ultrasensitive tPSA assay [abstract]
Clinical Chemistry 2008 Jun;54(6):C119 [ISI 000256325700422]
Eissa A, Diamandis EP.
Cloning, expression, and characterization of kallikrein-related peptidase-8 (KLK8) in Pichia pastoris [abstract]
Journal of Investigative Dermatology 2008 Apr;128:S103 [ISI 000254353800611]
Linbo RA, Vandell AG, Larson NS, Keegan MB, Blaber SI, Blaber M, Sneve DM, Lucchinetti CF, Rodriguez M, Diamandis EP, Scarisbrick IA.
Association of kallikreins with neuron loss and progressive multiple sclerosis [abstract]
Annals of Neurology 2008;64:S58 [ISI 000258923700233]

2007

Diamandis EP.
Novel biomarkers for prognosis and therapy response in ovarian cancer [abstract]
EJC Supplements 2007 Nov;5(8):13 [ISI 000251705800021]
Oikonomopoulou K, Hansen KK, Chapman K, Vergnolle N, Diamandis EP, Hollenberg MD.
Kallikrein-mediated activation of PARs in inflammation and nociception [abstract]
Inflammation Research 2007 Jun;56:S392 [ISI 000247517900123]
Diamandis EP.
Kallikrein enzymes as biomarkers for cancer [abstract]
Clinica Chimica Acta 2007 May;381(1):102 [ISI 000247513400028]
Bayani J, Planque C, Paliouras M, Shan SJ, Squires JA, Diamandis EP.
Chromosomal rearrangements of the kallikrein locus in human cancer cell lines [poster]
American Association for Cancer Research
AACR Annual Meeting Proceedings 2007 Apr;#1063 [AACR2007-1063p 812 KB]
Planque C, Soosaipillai A, Reckamp K, Chia D, Goodglick L, Diamandis EP.
Tissue kallikreins as serological biomarkers for lung cancer [poster]
American Association for Cancer Research
AACR Annual Meeting Proceedings 2007 Apr;#2679 [AACR2007-2679p 607 KB]
Paliouras M and Diamandis EP.
Intracellular signaling pathways regulate expression of Prostate Specific Antigen and other kallikreins in human breast cancer cells [poster]
American Association for Cancer Research
AACR Annual Meeting Proceedings 2007 Apr;#2901 [AACR2007-2901p 534 KB]
Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Diamandis EP, Hollenberg MD.
Tumour-derived proteinases and signalling: kallikrein-mediated PAR activation and inflammation [poster]
American Association for Cancer Research
AACR Annual Meeting Proceedings 2007 Apr;#3091 [AACR2007-3091p 354 KB]
Paliouras M and Diamandis EP.
Androgens act synergistically to enhance estrogen-induced up-regulation off human tissue kallikreins in breast cancer cells [poster]
American Association for Cancer Research
AACR Annual Meeting Proceedings 2007 Apr;#4328 [AACR2007-4328p 320 KB]
Prassas I, Paliouras M, Diamandis EP.
High-throughput screening for modulators of tissue-kallikrein expression [poster]
American Association for Cancer Research
AACR Annual Meeting Proceedings 2007 Apr;#5554 [AACR2007-5554p 849 KB]
Rabien A, Fritzsche FR, Jung M, Diamandis E, Loaning SA, Jung K, Kristiansen G, Stephan C.
High expression levels of the human kallikrein-like peptidases KLK14 and KLK15 in prostatic adenocarcinoma are associated with elevated risk of prostate-specific antigen relapse [abstract]
European Urology Supplements 2007 Mar;6(2):49 [ISI 000244422600106]
Rentsch CA, Wettenwald A, Diamandis E, Cecchini MG, Studer UE, Thalmann GN.
Expression of polycomb group gene BMI-1 is low in primary prostate cancer but high in its metastases [abstract]
European Urology Supplements 2007 Mar;6(2):148 [ISI 000244422600503]
Fischer SE, Kulasingam V, Diamandis EP, Ezzat S, Asa SL.
Thyroid cancer biomarker discovery using two-dimensional liquid chromatography-tandem mass spectrometry (2D-LC-MS/MS) [abstract]
Modern Pathology 2007 Mar;20:101A [ISI 000244922400448]
Fischer SE, Kulasingam V, Diamandis EP, Ezzat S, Asa SL.
Thyroid cancer biomarker discovery using two-dimensional liquid chromatography-tandem mass spectrometry (2D-LC-MS/MS) [abstract]
Laboratory Investigation 2007 Mar;87:101A [ISI 000244935300448]
Rabien A, Fritzsche FR, Jung M, Diamandis E, Loening SA, Jung K, Stephan C, Kristiansen G.
KLK14 and KLK15 expression in prostate cancer is associated with shortened disease-free survival after radical prostatectomy [abstract]
Pathology Research and Practice 2007;203(5):320 [ISI 000247312300170]

2006

Cho CKJ, Diamandis EP.
Proteomic analysis of normal human amniotic fluid by two-dimensional liquid chromatography and mass spectrometry [abstract]
Molecular & Cellular Proteomics 2006 Oct;5(10):S371 [ISI 000241506401433]
Heshmat SM, Jarvi K, Diamandis EP, Mullen B, Lo KC.
Seminal plasma lipocalin type PGDS: A new marker for obstructive azoospermia [abstract]
Fertility and Sterility 2006 Sep;86:S376 [ISI 000241038501416]
Darling M, Jackson L, Daley T, Diamandis E.
Human kallikrein expression in salivary gland tumors [poster]
International Academy of Pathology
Modern Pathology 2006 Sep;19(Suppl 3):107#489 [ISI 000239999400490p 494 KB]
Fischer S, Kulasingam V, Paliouras M, Diamandis E, Ezzat S, Asa S.
Human thyroid cancer cell lines differentially express PSA, HK6, HK10 and HK11 [poster]
International Academy of Pathology
Modern Pathology 2006 Sep;19(Suppl 3):138#639 [ISI 000239999400640p 359 KB]
Kundig C, Cloutier SM, Aellen S, Felber LM, Chagas JR, Gygi CM, Jichlinski P, Leisinger HJ, Diamandis EP, Deperthes D.
Human kallikrein 2 (HK2) inhibitors suppress tumor growth of prostate cancer xenografts in nude mice [abstract]
Journal of Urology 2006 Apr;175(4):263 [ISI 000236039201381 106 KB]
Heshmat SM, Jarvi K, Mullen B, Diamandis EP, Lo KC.
Seminal plasma lipocalin type PGDS: A potential marker for the diagnosis of obstructive azoospermia [poster]
Journal of Urology 2006 Apr;175(4):523#1623 [ISI 000236039203343p 161 KB]
Komatsu N, Suga Y, Saijoh K, Liu AC, Khan S, Mizuno Y, Ikeda S, Jayakumar A, Clayman GL, Shirasaki F, Takehara K, Diamandis EP.
Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes [abstract]
Journal of Investigative Dermatology 2006 Apr;126:58 [ISI 000242891500347]
Borgono CA, Michael IP, Komatsu N, Sotiropoulou G, Jayakumar A, Wu H, Clayman GL, Blaber SI, Blaber M, Mikolajczyk SD, Diamandis EP.
Multiple human tissue Kallikreins are regulated by lympho-epithelial Kazal-type inhibitor and digest desmoglein 1 [abstract]
Journal of Investigative Dermatology 2006 Apr;126:60 [ISI 000242891500356]
Paliouras M, Diamandis EP.
Coordinated hormone regulation of multiple kallikreins in breast cancer cell lines [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 2;#91 [AACR2006-0091p 333 KB]
White NMA, Yousef GM, Diamandis EP, Dor� JJ.
The human kallikrein gene 6 (KLK6) in combination with CA125 is a more sensitive marker for ovarian cancer than CA125 alone [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 2;#94 [AACR2006-0094 10 KB]
Shan SJC, Katsaros D, Paliouras M, Rigault I, Puopolo M, Diamandis EP.
Up-regulation of human tissue kallikrein 6 in ovarian carcinoma [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 2;#102 [AACR2006-0102p 379 KB]
Paliouras M, Diamandis EP.
Investigating the role of intracellular signaling pathways in regulating kallikrein expression [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 3;#1655 [AACR2006-1655p 725 KB]
Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Andrade-Gordon P, Cottrell GS, Bunnett NW, Diamandis EP, Hollenberg MD.
Kallikrein 14 signaling through proteinase-activated receptors [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 3;#1686 [AACR2006-1686p 436 KB]
Memari N, Diamandis EP, Van der Kwast T.
Immunohistochemical localization and expression profiling of human kallikrein 12 in human prostate cancer tissues [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 3;#1980 [AACR2006-1980p 551 KB]
Shaw JL, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP.
Development of an immunoassay for human kallikrein 15, a potential prostate and ovarian cancer biomarker [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 3;#1985 [AACR2006-1985p 237 KB]
Memari N, Grass L, Karakucuk EI, Shaw JL, Diamandis EP.
Protein expression, antibody generation, and development of a highly sensitive immunoassay for the detection of human tissue kallikrein 9 [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 3;#2889 [AACR2006-2889p 413 KB]
Sardana G, Marshall J, Diamandis EP.
Identification and characterization of novel candidate prostate cancer biomarkers through proteomic analysis of the secretome of three prostate cancer cell lines [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 4;#3572 [AACR2006-3572p 471 KB]
Kulasingam V, Diamandis EP.
Comparative qualitative proteomic analysis of conditioned media from breast cancer cell lines [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 4;#3573 [AACR2006-3573p 1.1 MB]
Petraki C, Papanastasiou PA, Karavana VN, Diamandis EP.
Immunohistochemical expression of human tissue kallikreins in neoplasms of various organs [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 4;#4358 [AACR2006-4358 10 KB]
Emami N, Michael IP, Diamandis EP.
Proteolytic cascades of human tissue kallikreins [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 4;#4368 [AACR2006-4368p 469 KB]
Oikonomopoulou K, Shannon P, Petraki CD, Diamandis EP.
Immunohistochemical localization of kallikrein 6 in brain tumors [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 4;#4488 [AACR2006-4488p 1.2 MB]
Shan SJC, Scorilas A, Soosaipillai A, Katsaros D, Rigault I, Puopolo M, Diamandis EP.
Human tissue kallikrein 7 over-expression in ovarian carcinoma: a novel marker of unfavorable prognosis [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 4;#4503 [AACR2006-4503p 383 KB]
Simon I, Diamandis EP, Katsaros D, Kim NW, Wolfert RL.
B7-H4 (DD-O110) protein is over-expressed in early-stage ovarian cancer tumor tissue [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2006 Apr 4;#4505 [AACR2006-4505p 405 KB]
Borgono CA, Michael IP, Komatsu N, Sotiropoulou G, Jayakumar A, Wu H-K, Clayman GL, Blaber SI, Blaber M, Mikolajczyk SD, Diamandis EP.
Multiple human tissue kallikreins are regulated by lympho-epithelial Kazal-type inhibitor and digest desmoglein 1 [poster]
Society for Investigative Dermatology
Journal of Investigative Dermatology 2006 Apr;(Suppl):#? [SID2006-p 166 KB]
Oikonomopoulou K, Hansen K, Saifeddine M, Diamandis EP, Hollenberg MD.
Kallikrein signaling in cancer via proteinase-activated receptors [abstract]
7th Conference on Signalling in Normal and Cancer Cells
National Institutes of Health Proteomics International Group 2006 Mar;#85 [Abs372 343 KB]
Fischer SE, Diamandis EP, Ezzat S, Asa SL.
SELDI-TOF mass spectrometry analysis of normal, benign and malignant thyroid tissue [poster]
International Academy of Pathology
Modern Pathology 2006 Jan;19(Suppl 1):93A#420 [ISI 000234094500420p 394 KB]
Fischer SE, Diamandis EP, Ezzat S, Asa SL.
SELDI-TOF mass spectrometry analysis of normal, benign and malignant thyroid tissue [poster]
International Academy of Pathology
Laboratory Investigation 2006 Jan;86(Suppl 1):93A#420 [ISI 000234207600420p 394 KB]
Vivian B, Sherman Y, Edelman D, Peretz T, Diamandis EP.
Prognostic kalhkrein markers for ovary cancer [abstract]
Tumor Biology 2006;27:9 [ISI 000203408000017]
Diamandis EP.
Cancer biomarker discovery and validation by mass spectrometry [abstract]
Tumor Biology 2006;27:11 [ISI 000203408000021]
Diamandis EP.
Human tissue Kallikreins [abstract]
Tumor Biology 2006;27:32 [ISI 000203408000064]
Komatsu N, Suga Y, Saijoh K, Liu AC, Khan S, Mizuno Y, Ikeda S, Jayakumar A, Clayman GL, Shirasaki F, Takehara K, Diamandis EP.
Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes [poster]
Society for Investigative Dermatology
Journal of Investigative Dermatology 2006;126#348 [SID2006-348p 1.9 MB]

2005

Schmalfeldt B, Kates R, Dorn J, Scorilas A, Grass L, Soosaipillai A, Diamandis E, Kiechle M, Schmitt M, Harbeck N.
Impact of proteolytic factors on surgical success and survival in ovarian cancer [abstract]
Journal of Clinical Oncology 2005 Jun 1;23(16):471S [ISI 000230326603111 104 KB]
Schmitt M, Kates R, Dorn J, Scorilas A, Grass L, Soosaipillai A, Diamandis E, Kiechle M, Schmalfeldt B, Harbeck N.
Impact of proteolytic factors (uPA, PAI-I, tissue kallikreins) on surgical success and survival in ovarian cancer [abstract]
Thrombosis and Haemostasis 2005 Apr;93(4):A24 [ISI 000228393000121]
Diamandis EP, Van der Merwe D-E, Simon I, Kobayashi H, Terao T.
Multiparametric analysis of six tissue kallikreins and CA125 for ovarian cancer diagnosis [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005 Apr 20;376#5598 [AACR2005-5598p 152 KB]
Komatsu N, Saijoh K, Sidiropoulos M, Tsai B, Levesque MA, Elliott MB, Takehara K, Diamandis EP.
Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender [abstract]
Society for Investigative Dermatology
Journal of Investigative Dermatology 2005 Apr;124(4):A57 [ISI 000228179900342 11 KB]
Yousef GM, Katsaros D, Diamandis EP.
The kallikrein proteins: New potential biomarkers for ovarian cancer [poster]
International Academy of Pathology
Modern Pathology 2005 Jan;18(Suppl 1):209A#972 [ISI 000226117901125p 506 KB]
Yousef GM, Katsaros D, Diamandis EP.
The kallikrein proteins: New potential biomarkers for ovarian cancer [poster]
International Academy of Pathology
Laboratory Investigation 2005 Jan;85(Suppl 1):209A#972 [ISI 000226238601145p 506 KB]
White NM, Yousef GM, Michael IP, Robb JD, Diamandis EP.
Differential expression of the human kallikrein 10 gene (KLK10), a candidate cancer biomarker [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;83#36 [AACR2005-0036 13 KB]
Yousef GM, White NMA, Borgono CA, Ellatif MA, Soosaipillai A, Robb, JD, Diamandis EP.
Kallikreins are potential biomarkers for pancreatic and colon cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;83#37 [AACR2005-0037 13 KB]
Elliott MB, Michael IP, Kuk C, Yousef G, Diamandis EP.
Identification of single nucleotide polymorphisms in the human kallikrein locus: Potential association with cancer susceptibility [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;83#39 [AACR2005-0039 11 KB]
Yousef GM, Elliott MB, White NMA, Borgono CA, Robb JD, Michael IP, Economopoulou K, Diamandis EP.
Differential expression of the human kallikrein gene 6 (KLK6) in various malignancies [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;83#40 [AACR2005-0040 13 KB]
Memari N, Grass L, Bansil A, Cho J-C, Shan SJC, Soosaipillai A, Diamandis EP.
Production of the extracellular domain of Siglec-9 using an E-coli expression system and generation of anti-Siglec-9 [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;108#694 [AACR2005-0694p 584 KB]
Grutzmann R, Diamandis EP, Saeger H-D, Pilarsky C.
Human kallikrein 10 mRNA up-regulation but not serum increase of the protein in patients with pancreatic cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;133#1245 [AACR2005-1245 10 KB]
Petraki CD, Veloudis G, Komborozos VA, Scorilas A, Papanastasiou P, Diamandis EP.
Immunohistochemical evaluation and prognostic significance of human kallikreins 6 and 10 in colorectal cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;133#1260 [AACR2005-1260 11 KB]
Gunawardana G, Luo L-Y, Diamandis EP.
Retrieval of autoantibodies from ovarian cancer cells present in ascites fluid [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;143#1534 [AACR2005-1534 951 KB]
Borgono CA, Soosaipillai A, GrassL, Diamandis EP.
Development of a novel immunoassay for human kallikrein 14, a putative ovarian and breast cancer biomarker [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;143#1547 [AACR2005-1547 13 KB]
Michael IP, Yousef GM, Soosaipillai A, Grass L, Diamandis EP.
A novel ELISA assay for human kallikrein 5, a candidate breast and ovarian cancer biomarker [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;143#1548 [AACR2005-1548 13 KB]
Shaw JL, Obiezu C, Memari N, Karakucuk I, Diamandis EP.
Production of recombinant human kallikrein 15, a potential prostate and ovarian cancer biomarker [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;143#1549 [AACR2005-1549 13 KB]
Sidiropoulos M, Pampalakis G, Sotiropoulou G, Diamandis EP.
Expression of human tissue kallikrein 5 in breast and prostate cancer cell lines after treatment with the demethylating agent 5-aza-2'-deoxycytidine [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;175#1842 [AACR2005-1842 10 KB]
Shan SJC, Michael IP, Soosaipillai A, Katsaros D, Rigault de la Longrais IA, Puopolo M, Diamandis EP.
Over-expression of human kallikrein 6 (hK6) protein and mRNA in ovarian carcinoma [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;176#1860 [AACR2005-1860 27 KB]
Leoutsakou T, Talieri M, Mathioudaki K, Stavropoulou P, Arnogianaki N, Diamandis EP, Scorilas A.
Expression analysis and prognostic significance of SR-A1 gene, encoding for a new member of the human ser/arg-rich family of pre-mRNA splicing factors, in breast and ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;177#1899 [AACR2005-1899 14 KB]
Memari N, Grass L, Michael IP, Fountas NP, Diamandis EP.
Hormonal regulation of human tissue kallikrein 9 in human cancer cell lines [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;187#2141 [AACR2005-2141p 229 KB]
Michael IP, Harris JL, Li J, Gavigan J-A, Borgono CA, Bowles B, Diamandis EP.
Characterization of human kallikrein 5 (hK5) substrate specificity using combinatorial peptide libraries [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;229#2956 [AACR2005-2956 16 KB]
Michael IP, Komatsu N, Jayakumar A, Kang Y, Clayman GL, Diamandis EP.
Regulation of the proteolytic activity of human kallikrein 5 (hK5) by tissue and plasma inhibition [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;229#2970 [AACR2005-2970 15 KB]
Dorn J, Harbeck N, Kates R, Scorilas A, Grass L, Soosaipillai A, Diamandis EP, Kiechle M, Schmalfeldt B, Schmitt M.
Analysis of the differential expression of proteolytic factors uPA, PAI-I and seven tissue kallikreins (hK5, 6, 7, 8, 10, 11, 13) between primary ovarian carcinoma tissues and corresponding omentum metastases [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;229#2972 [AACR2005-2972 13 KB]
Borgono CA, Felber LM, Cloutier SM, Deperthes D, Li J, Gavigan J-A, Harris JL, Bowles B, Diamandis EP.
Enzymatic profiling of human kallikrein 14, a candidate cancer biomarker, by phage display substrate and positional scanning peptide libraries [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;229#2975 [AACR2005-2975 16 KB]
Sardana G, Marshall J, Grass L, Soosaipillai A, Diamandis EP.
Proteomic analysis of culture supernatants from prostate cancer cell lines [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;234#3105 [AACR2005-3105p 485 KB]
Luo L-Y, Soosaipillai A, Du D, Diamandis EP.
Purification and characterization of human kallikrein 11, a candidate prostate cancer biomarker, from seminal plasma [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;236#3157 [AACR2005-3157 15 KB]
van der Merwe D-E, Diamandis EP.
Mass spectrometry as a cancer diagnostic tool: a meta-analysis of published data [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;307#4361 [AACR2005-4361 10 KB]
Oikonomopoulou K, Scorilas A, Grass L, Soosaipillai A, Rosen B, Murphy J, Diamandis EP.
Kallikreins as markers of disseminated tumour cells in ovarian cancer [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;332#4878 [AACR2005-4578p 752 KB]
Michael IP, Pampalakis G, Mikolajczyk SD, Malm J, Sotiropoulou G, Diamandis EP.
Involvement of human kallikreins in a proteolytic cascade pathway in the prostate [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;330#4835 [AACR2005-4835 14 KB]
Oikonomopoulou K, Simon I, Wolfert RL, Valik D, Nekulova M, Simickova M, Frgala T, Diamandis EP.
Evaluation of human kallikreins 5, 6, 7, 8, 10 and 11 as prognostic markers in serum of ovarian cancer patients [poster]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;332#4877 [AACR2005-4877p 329 KB]
Simon I, Kim NW, Diamandis EP, Valik D, Mekulova M, Simickova M, Frgala T, Sarno MJ, Wolfert RL.
Evaluation of B7-H4 (DD-O110) as a prognostic marker in tissue and serum of ovarian cancer patients [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2005;332#4882 [AACR2005-4882 16 KB]
Van Der Merwe D, Diamandis EP.
Cancer biomarker discovery and validation by mass spectrometry [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2005;51:A61 [ISI 000229452500193 87 KB]
Schmalfeldt B, Kates R, Dorn J, Scorilas A, Grass L, Soosaipillai A, Diamandis EP, Kiechle M, Schmitt M, Harbeck N.
Impact of proteolytic factors on surgical success and survival in ovarian cancer [abstract]
American Society of Clinical Oncology
Proceedings of the American Society of Clinical Oncology 2005;471#5068 [ASCO2005-5068 50 KB]
Diamandis EP.
Human tissue kallikreins as biomarkers for breast, ovarian and other malignancies [abstract]
Era of Hope
Proceedings of Era of Hope 2005;100#P13-9 [Abs352 14 KB]
Oikonomopoulou K, Hansen K, Saifeddine M, Diamandis EP, Hollenberg MD.
Cell signaling via proteinase-activated receptors (PARS): A new role for kallikreins [abstract]
International Proteolysis Society
4th General Meeting of the International Proteolysis Society 2005;79#PI6 [IPS2005-PI6]

2004

Yousef GM, Polymeris M, White N, Robb J-D, Yacoub GM, Raouf AA, Diamandis EP.
Kallikreins are potential new breast cancer biomarkers [abstract]
Pathology -- Research & Practice 2004;200:655#70 [Path2004-70 86 KB]
Yousef GM, Polymeris M, Hutchinson S, Robb J-D, Soosaipillai A, Serry E, Diamandis EP.
The human kallikrein proteins 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors [abstract]
Pathology -- Research & Practice 2004;200:655#71 [Path2004-71 79 KB]
Economopoulou K, Diamandis EP.
Kallikrein 6 as a biomarker for the detection of metastatic cancer cells in blood of ovarian cancer patients [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:241#1058 [AACR2004-1058 26 KB]
Scorilas A, Mathioudaki K, Leoutsakou T, Arnaouti M, Diamandis EP.
Expression analysis of the SR-A1 gene, encoding for a novel member of the human Ser/Arg-rich family of proteins, in breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:397-98#1728 [AACR2004-1728 25 KB]
Borgono CA, Ghosh MC, Michael IP, Stoop A, Craik CS, Choe Y, Kapadia C, Diamandis EP.
Enzymatic action, substrate specificity and regulation of human kallikrein 14 (hK14) [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:415#1807 [AACR2004-1807 26 KB]
Luo L-Y, Grass L, Soosaipillai A, Diamandis EP.
Trypsin-like enzymatic activity of human kallikrein 10 [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:416#1810 [AACR2004-1810 24 KB]
Petraki CD, Gregorakis AK, Papanastassiou A, Diamandis EP.
The immunohistochemical expressionof human kallikreins 5, 6, 10 and 11 in normal urothelium and urinary bladder cancer. Correlation with histopathological variables [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:417#1815 [AACR2004-1815 26 KB]
Kapadia C, Ghosh MC, Stoop A, Craik CS, Choe Y, Borgono C, Diamandis EP.
Human kallikrein 13: Evaluation of its role in the degradation of extracellular matrix proteins and characterization of its substrate specificity [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:417-18#1819 [AACR2004-1819 26 KB]
Michael IP, Sotiropoulou G, Pampalakis G, Magklara A, Wasney GA, Diamandis EP.
Human kallikrein 5 (hK5): Autoactivation, substrate specificity, regulation by inhibitors and cleavage of extracellular matrix and basement membrane components [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:529#2294 [AACR2004-2294 27 KB]
Yousef GM, White N, Kurlender L, Michael I, Desmond-Robb J, Memari N, Grass L, Diamandis EP.
The KLK5-splice variant 2 is a new biomarker for ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:764#3300 [AACR2004-3300 26 KB]
Petraki CD, Vaslamatzis MM, Petraki KD, Diamandis EP.
Correlation between the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 and histopathological variables in colorectal cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:766#3306 [AACR2004-3306 24 KB]
Pampalakis G, Diamandis EP.
Cloning and characterization of novel isoforms of the human kallikrein 6 gene [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:798#3454 [AACR2004-3454 80 KB]
Kurlender L, Yousef GM, Diamandis EP.
Differential expression of a novel KLK5 splice variant in ovarian and prostate cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:838#3632 [AACR2004-3632 27 KB]
Michael IP, Kurlender L, Yousef GM, Memari N, Du DC, Katsaros D, Diamandis EP.
Novel alternative splicing events within the human kallikrein locus [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:979#4243 [AACR2004-4243 26 KB]
Borgono CA, Kishi T, Scorilas A, Harbek N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
Human kallikrein 8 protein (hK8) in ovarian cancer cytosols: A new marker of favorable prognosis [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:1025#4444 [AACR2004-4444 26 KB]
Luo L-Y, Soosaipillai A, Grass L, Diamandis EP.
Human kallikreins 6 and 10 are secreted as zymogen forms in ascites fluid from ovarian cancer patients [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:1025-2#4447 [AACR2004-4447 25 KB]
Memari N, Hussack G, Cui S, Grass L, Diamandis EP.
Production of polyclonal antibodies against human tissue kallikrein 9 [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:1027#4452 [AACR2004-4452 27 KB]
Yousef G, Polymeris M-E, Yaboub GM, Fracchioli S, Scorilas A, Soosaipillai A, Popalis C, Desmond-Robb J, Katsaros D, Diamandis EP.
In silico analysis of kallikrein gene expression in ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:1029#4461 [AACR2004-4461 27 KB]
Obiezu CV, Michael IP, Wasney GA, Diamandis EP.
Enzymatic activity of prostase/human kallikrein 4 (hK4): Determination of substrate preferences and degradation of extracellular matrix proteins [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:1032#4474 [AACR2004-4474 24 KB]
Stephan C, Chianlian X, Kishi T, Nakamura T, Brown DA, Breit SN, Cammann H, Jung K, Diamandis EP.
Artificial neural network based on PSA, percent free PSA, and three new prostate cancer biomarkers [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:1033#4478 [AACR2004-4478 24 KB]
Memari N, Grass L, Hussack G, Soosaipillai A, Diamandis EP.
Production of polyclonal and monoclonal antibodies against human tissue kallikrein 12 [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:1212-1#5257 [AACR2004-5257 27 KB]
Yousef G, Popalis C, Polymeris M-E, White N, Desmond-Robb J, Yacoub GM, Soosaipillai A, Diamandis EP.
Kallikrein gene down-regulation in breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2004;45:1213#5258 [AACR2004-5258 26 KB]
Katsaros D, Fracchioli S, Rigault de la Longrais IA, Diamandis EP.
Human kallikreins (hKs) as novel serum biomarkers for diagnosis, prognosis and monitoring of epithelial ovarian carcinoma [abstract]
EORTC-NCI
International Journal of Biological Markers 2004;19(S3):S29 [Abs319 11 KB]
Simon I, Kim NW, Sarno M, Diamandis EP, Valik D, Nekulova M, Simickova M, Frgala T, Wolfert RL.
Characterization of three novel serum biomarkers for the early detection and prognosis of ovarian cancer [poster]
MD Anderson Cancer Center 5th International Conference
2004 [MDA2004p 680 KB]

2003

Barak V, Sherman Y, Doviner V, Edelman D, Diamandis EP.
Kallikreins 6 and 10 as prognostic marks of ovarian cancer [abstract]
Clinical Ligand Assay Society
Journal of Clinical Ligand Assay 2003 Dec;26(4):215#16 [CLAS2003-16 132 KB]
Yousef GM, Polymeris M, Yacoub GM, Fracchioli S, Scorilas A, Soosaipillai A, Popalis C, Katsaros D, Diamandis EP.
In silico analysis of kallikrein gene expression in ovarian cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2003 Jun;49(6):A96#D-23 [ISI 000183088700300 101 KB]
Yousef GM, Borgono C, Polymeris M, Soosaipillai A, Scorilas A, Harbeck N, Schmalfeldt B, Dorn J, Schmitt M, Chan P, Diamandis EP.
Human kallikrein 5 (hK5): A novel serum biomarker for ovarian and breast cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2003 Jun;49(6):A96#D-24 [ISI 000183088700301 100 KB]
Nam RK, Zhang W, Trachtenberg J, Diamandis E, Jewett MA, Narod SA.
A single nucleotide polymorphism of the human kallikrein-2 gene (KLK2) highly correlates with serum HK2 levels and in combination enhances prostate cancer detection [abstract]
Journal of Urology 2003 Apr;169(4):384 [ISI 000181721401484 109 KB]
Nakamura T, Scorilas A, Stephan C, Jung K, Soosaipillai AR, Diamandis EP.
Analysis of serum human kallikrein 11 (hK11) for discriminating between prostate cancer and benign prostatic hyperplasia [abstract]
Journal of Urology 2003 Apr;169(4):385 [ISI 000181721401485 114 KB]
Diamandis EP.
Practice guidelines for tumour markers [abstract]
Tumour Biology 2003;24:23#S-46 [Abs298 224 KB]
Yousef GM. Borgono CA, Scorilas A, Fracchioli S, Iskander L, Rigault de la Longrais IA, Puopolo M, Diamandis EP.
Prognostic value of human kallikrein gene 14 (KLK14) in ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:90#477 [AACR2003-0477 11 KB]
Diamandis EP, Scorilas A, Yousef G, Kishi T, Luo L-Y, Nakamura T, Rademaker AW, Liu D, Fishman DA.
Multiparametric serum analysis of human kallikreins hK5, hK6, hK7, hK8, hK10 and hK11 in combination with CA125 for ovarian cancer diagnosis [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:90#478 [AACR2003-0478 10 KB]
Kapadia C, Chang A, Sotiropoulou G, Yousef G, Grass L, Soosaipillai A, Diamandis EP.
Development of a sensitive and specific immunofluorometric assay to measure human kallikrein 13 which is overexpressed in ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:90-91#479 [AACR2003-0479 10 KB]
Kishi T, Grass L, Soosaipillai A, Memari N, Little SP, Diamandis EP.
Is human kallikrein 7 a new serum biomarker for ovarian cancer? [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:91#480 [AACR2003-0480 10 KB]
Kishi T, Grass L, Soosaipillai A, Scorilas A, Memari N, Shimizu-Okabe C, Schmitt M, Harbeck N, Dorn J, Schmalfeldt B, Diamandis EP.
Human kallikrein 8 as a serum biomarker for ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:91#481 [AACR2003-0481 10 KB]
Pampalakis G, Diamandis EP, Sotiropoulou G.
CpG island methylation as a basis for the aberrant expression of the protease M/human kallikrein 6 gene in breast Tumour cells [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:222#1116 [AACR2003-1116 11 KB]
Sidiropoulos M, Pampalakis G, Sotiropoulou G, Diamandis EP.
CPG island hypermethylation as a basis for differential NES-1/KLK10 gene expression in breast, ovarian and prostate cancers [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:#1121 [AACR2003-1121 10 KB]
Scorials A, Chang P, Katsaros D, Yousef G, Diamandis EP.
Cloning of a new gene, CEAL1, which encodes for a carcinoembryonic antigen-like protein: Overexpression in aggressive ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:244#1238 [AACR2003-1238 10 KB]
Stephan C, Finne P, Stenman U-H, Cammann H, Jung K, Diamandis EP.
Comparison of two different artificial neural networks for prostate biopsy indication in two different patient populations [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:489-90#2489 [AACR2003-2489 12 KB]
Nakamura T, Scorilas A, Stephan C, Jung K, Soosaippillai AR, Miki T, Diamandis EP.
The analysis of serum human kallikrein 11 (hK11) increases discrimination between prostate cancer and benign prostatic hyperplasia [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:490#2490 [AACR2003-2490 10 KB]
Kurlender L L, Yousef G, Chang A, Diamandis EP.
Differential expression of kallikrein gene splice variants in cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:626#3156 [AACR2003-3156 10 KB]
Magklara A, Mellati AA, Wasney G, Sotiropoulou G, Diamandis EP.
Characterization of the enzymatic activity of human kallikrein 6 (hK6/zyme) and regulation by inhibitors [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:669-70#3365 [AACR2003-3365 12 KB]
Kapadia C, Grass L, Wasney G, Obiezu C, Yousef G, Diamandis EP.
Human kallikrein 13, a potential ovarian cancer marker, binds to alpha 1 antichymotrypsin, alpha 2 macroglobulin and alpha 2 antiplasmin [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:670#3366 [AACR2003-3366 12 KB]
Yousef GM, Borgono, Scorilas A, Ponzone R, Biglia N, Roagna R, Sismondi P, Diamandis EP.
Human kallikrein gene 14 (KLK14) expression: An indicator of poor prognosis in breast cancer patients [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:670#3367 [AACR2003-3367 11 KB]
Yousef GM, Kurlender LE, Borgono CA, Grass L, Diamandis EP.
Regulation of human kallikrein gene 14 (KLK14) by steroids in breast and ovarian cancer cell lines [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:713#3385 [AACR2003-3585 11 KB]
Memari N, Grass L, Michael IP, Obiezu CV, Diamandis EP.
Hormonal regulation of human tissue kallikrein 12 in prostate, breast and ovarian cancer cell lines [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:713-14#3586 [AACR2003-3586 11 KB]
Luo LY, Grass L, Diamandis EP.
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:837#4205 [AACR2003-4205 10 KB]
Stephan C,Cammann H, Graefen M, Haese A, Djavan B, Remzi M, Semjonow A, Oberpenning F, Finne P, Stenman U-H, Jung K, Diamandis EP.
Evaluation of a common program for predicting the outcome of prostate biopsy with 4 different PSA assays at PSA 2-10 ng/ml based on 4366 patients [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:880#4438 [AACR2003-4438 11 KB]
Michael I, Diamandis E.
Expression profiling of the 15 human kallikrein genes [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:998#5003 [AACR2003-5003 10 KB]
Nakamura T, Stephan C, Scorilas A, Memari N, Yousef GM, Jung K, Diamandis EP.
Quantitative analysis of KLK11 gene expression in prostatic tissues [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:999#5006 [AACR2003-5006 10 KB]
Nakamura T, Scorials A, Stephan C, Yousef GM, Kristiansen G, Jung K, Diamandis EP.
Macrophage inhibitory cytokine 1 (MIC-1) gene is up-regulated in human prostatic cancer tissues [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:1001-2#5019 [AACR2003-5019 10 KB]
Obiezu CV, Yousef GM, Jung K, Stephan C, Scorilas A, Diamandis EP.
Kallikrein gene 5 is differentially expressed in healthy vs cancerous testicular tissues [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:1006-0#5046 [AACR2003-5046 10 KB]
Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastassiou PA, Yousef GM, Diamandis EP.
The immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Correlation with several prognostic factors [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:1077#5412 [AACR2003-5412 13 KB]
Petraki CD, Papanastassiou PA, Gregorakis AK, Karavana VN, Luo L, Diamandis EP.
Down-regulation of human kallikreins 6, 10 and 13 in prostate cancer and correlation with established prognostic parameters [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:1077#5413 [AACR2003-5413 11 KB]
Borgono CA, Soosaipillai A, Grass L, Fracchioli S, Yousef GM, Katsaros D, Diamandis EP.
Development of an immunofluorometric assay for human kallikrein 14 (hK14): Preliminary clinical applications [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:1146-7#5745 [AACR2003-5745 11 KB]
Borgono CA, Yousef GM, Scorilas A, Grass L, Soosaipillai A, Diamandis EP.
Human kallikrein 14 (hK14) expression in breast cancer tissues [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:1264#6328 [AACR2003-6328 11 KB]
Yousef GM, Grass L, Polymeris M-E, Soosaipillai A, Chan P-C, Scorials A, Borgono CA, Harbeck N, Schmalfeldt B, Dorn J, Schmitt M, Diamandis EP.
Human kallikrein 5 (hK5): A novel serum biomarker for breast and ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2003;44:1266#6337 [AACR2003-6337 13 KB]
Yousef GM, Borgo�o CA, Robb D, Scorilas A, Ponzone R, Diamandis EP.
Human Kallikrein Gene 14 (KLK14) Expression: An Indicator of Poor Prognosis in Breast Cancer Patients [abstract]
American College of Obstetricians and Gynecologists
ACOG 7th Annual Winter Symposium 2003;#266 [ACOG2003-266 24 KB]
Fracchioli S, Borgono CA, Yousef GM, Rigault de La Longrais IA, Puopolo M, Massobrio M, Diamandis EP, Katsaros D.
Human kallikrein 11 (hK11) and 15 (hK15) expression in ovarian cancer: New independent predictive and prognostic factors [abstract]
American Society of Clinical Oncology
Proceedings of the American Society of Clinical Oncology 2003;22:#3462 [ASCO2003-3462 46 KB]
Antoniou A, Papanastasiou P, Stefanides A, Diamandis E, Androulakakis PA.
Assessment of serum PSA in childhood [abstract]
European Society for Pediatric Urology, XIVth Annual Meeting
Proceedings of the European Society for Pediatric Urology, XIVth Annual Meeting 2003;41-42#E-60 [Abs267]

2002

Yousef GM, Diamandis EP.
Prognostic value of kallikreins in endocrine-related malignancies [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2002 Jun;48(6):A25 [ISI 000176038000078 96 KB]
Yousef GM, Scorilas A, Borgono C, Fracchioli S, Richiardi G, Massobrio M, Katsaros D, Diamandis EP.
Prognostic value of the human kallikrein gene 14 (KLK14) in ovarian cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2002 Jun;48(6):A25 [ISI 000176038000079 70 KB]
Yousef GM, Scorilas A, Fracchioli S, Iskander L, Raouf AA, Massobrio M, Katsaros D, Diamandis EP.
KLK15 is a new potential independent marker for unfavorable prognosis in ovarian cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2002 Jun;48(6):A148 [ISI 000176038000482 74 KB]
Nakamura T, Mitsui S, Okui A, Miki T, Yamaguchi N, Diamandis EP.
Human kallikrein 11; A new biomarker of prostate cancer [abstract]
Journal of Urology 2002 Apr;167(4):286 [ISI 000184566701153 88 KB]
Cutz JC, Diamandis M, Ezzat S, Diamandis EP, Asa SL.
Identification of the protein immunoreactive to the monoclonal antibody HBME-1 in thyroid neoplasia [abstract]
International Academy of Pathology
Laboratory Investigation 2002 Jan;82(1):113A#467 [ISI 000173379700480 79 KB]
Cutz JC, Diamandis M, Ezzat S, Diamandis EP, Asa SL.
Identification of the protein immunoreactive to the monoclonal antibody HBME-1 in thyroid neoplasia [abstract]
International Academy of Pathology
Modern Pathology 2002 Jan;15(1):113A#467 [ISI 000173388900484 80 KB]
Kollara A, Casper RF, Diamandis EP, Brown TJ.
Differential expression of two androgen receptor associated protein 70 (ARA70) isoforms induced by androgen and resveratrol in androgen receptor transfected human prostate cancer PC-3 cells [abstract]
The Endocrine Society 2002;368#P2-200 [Abs256 141 KB]
Chang A, Yousef GM, Kapadia C, Scorilas A, Ponzone R, Diamandis EP.
Favorable prognostic value of KLK13 gene expression in breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:45#230 [AACR2002-0230 10 KB]
Yousef GM, Fracchioli S, Kyriakopoulou L, Zarghooni M, Scorilas A, Diamandis M, Puopolo M, Massobrio M, Diamandis EP, Katsaros D, Danese S.
A new potential independent prognostic marker for ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:47#236 [AACR2002-0236 10 KB]
Borgo�o CA, Katsaros D, Luo L-Y, Fracchioli S, Yamaguchi N, Soosaipilla A, Grass L, Rigault de la Longrais IA, Puopolo M, Yousef GM, Scorilas A, Diamandis EP.
The prognostic value of human kallikrein 11 (hK11, trypsin-like serine protease, TLSP) in ovarian cancer cytosols [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:47#237 [AACR2002-0237 12 KB]
Diamandis EP, Okui A, Mitsui S, Luo L-Y, Soosaipillai AR, Grass L, Nakamura T, Howarth DJC, Yamaguchi N.
Human kallikrein 11: a potential new serum biomarker for prostate and ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:47#238 [AACR2002-0238 10 KB]
Zarghooni M, Bharaj B, Fracchioli S, Katsaros D, Rigault de la Longrais IA, Diamandis EP, Puopolo M.
Identification of two novel single nucleotide polymorphisms (SNPs) within the human kallikrein 6 gene [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:53-54#270 [AACR2002-0270 10 KB]
Yousef GM, Magklara A, Borgo�o C, Memari N, Abd Ellatif M, Grass L, Diamandis EP.
Regulation of the human kallikrein gene 15 (KLK15) by steroids in breast cancer cell lines [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:117#587 [AACR2002-0587 15 KB]
Luo L-Y, Herrera I, Soosaipillai A, Diamandis EP.
Identification of heat shock protein 90 as Tumour antigen in ovarian cancer by serological screening [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:279#1384 [AACR2002-1384 10 KB]
Stephan C, Yousef G, Scorilas A, Jung K, Jung M, Kristiansen G, Hauptmann S, Welsh JB, Hampton GM, Leoning SA, Dietel M, Diamandis EP.
Hepsin, potential new marker for prostate cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:388#1935 [AACR2002-1935 16 KB]
Scorilas A, Kletsas D, Katsaros N, Diamandis EP.
The new member of apoptosis-related proteins, BCL2L12, is down-regulated in aggressive breast Tumours and in arrested human fibroblasts [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:529#2622 [AACR2002-2622 10 KB]
Sotiropoulou G, Tsetsenis T, Rogakos V, Symillides G, Pampalakis G, Diamandis E, Yiotakis A.
Overexpression of active recombinant human kallikrein 13 and characterization of its proteolytic activity [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:538#2671 [AACR2002-2671 17 KB]
Petraki CD, Karavana VN, Gregorakis A, Papanastasiou P, Luo L-Y, Diamandis EP.
The immunoexpr3essinof human kallikrein 6 and 10 in benign and malignant prostatic tissues [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:563#2793 [AACR2002-2793 15 KB]
Yousef GM, Diamandis M, Stephan C, Jung K, Diamandis EP.
Testicular acid phosphatase (ACPT): a new gene which is down-regulated in testicular cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:630#3127 [AACR2002-3127 14 KB]
Scorilas A, Plebani M, Mazza S, Soosaipillai A, Katsaros N, Basso D, Pagano F, Diamandis EP.
Human glandular kallikrein 2 (hK2) and insulin-like growth factor (IGF-1) as discriminating markers between prostate cancer and benign prostatic hyperplasia [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:730#3620 [AACR2002-3620 14 KB]
Diamandis EP, Scorilas A, Yousef GM, Stenman U-H, Henrik A, Soosaipillai A, Grass L, Katsaros D.
Human Kallikrein 6: a novel serum biomarker for diagnosis, prognosis and monitoring of ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:741-2#3679 [AACR2002-3679 14 KB]
Luo L-Y, Fracchioli S, Scorilas A, Grass L, Vergote I, van der Zee A, Stenman U-H, Diamandis EP, Katsaros D.
Human kallikrein 10 is a new serum marker for ovarian cancer diagnosis and prognosis [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:743#3686 [AACR2002-3686 25 KB]
Kishi T, Grass L, Soosaipillai A, Shimizu-Okabe C, Diamandis EP.
Human kallikrein 8 (neuropsin) is a potential Tumour biomarker for ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:743#3688 [AACR2002-3688 10 KB]
Yousef GM, Stephan C, Scorilas A, Chang A, Rendl L, Diamandis M, Jung K, Diamandis EP.
Down-regulation of the human KLK5 gene in prostate cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:763#3786 [AACR2002-3786 10 KB]
Yousef GM, Memari N, Scorilas A, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP.
A new favorable prognostic marker for breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:916#4540 [AACR2002-4540 15 KB]
Memari N, Nakamura T, Kishi T, Yousef GM, Hoffman BR, Diamandis EP.
Cloning and protein expression of human kallikrein 12: A new poteintial biomarker for breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:917#4544 [AACR2002-4544 12 KB]
Kyriakopoulou LG, Scorilas A, Yousef G, Ponzone R, Biglia N, Roagna R, Cacciari F, Sismondi P, Diamandis EP.
Prognostic significance of human kallikrein 7 (KLK7) in breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:917-8#4548 [AACR2002-4548 11 KB]
Yousef GM, Bharaj B, Hoffman B, Poulopoulos J, Diamandis EP.
Identification of unique polymorphic minisatellites in the human kallikrein locus and their relation to malignancy [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:930-1#4609 [AACR2002-4609 11 KB]
Bharaj B, Luo L-Y, Jung K, Stephan C, Yu H, Diamandis EP.
Prostate cancer risk associated with single nucleotide polymorphism (SNP) of the human kallikrein 10 gene [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:931#4610 [AACR2002-4610 14 KB]
Stephan C, Jung K, Soosaipillai A, Cammann H, Leoning SA, Diamandis EP.
Clinical usefulness of human glandular kallikrein 2 within a neural network to improve prostate cancer detection [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:1067#5286 [AACR2002-5286 14 KB]
Stephan C, Yousef GM, Scorilas A, Nakamura T, Kishi T, Jung M, Jung K, Kristiansen G, Hauptmann S, Diamandis EP.
Quantitative analysis of kallikrein 15 expression in prostate tissues [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:1067-8#5287 [AACR2002-5287 16 KB]
Stephan C, Soosaipillai A, Jung K, Kristiansen G, Hauptmann S, Diamandis EP.
The value of serum hK2 for distinguishing pathological stage and grade of prostate cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:1068#5288 [AACR2002-5288 10 KB]
Obiezu CV, Soosaipillai A, Stephan C, Jung K, Howarth DHC, Diamandis EP.
Immunofluorometric and immunohistochemical detection of a PSA-related protein, prostase (human kallikrein 4), in normal and cancerous prostatic tissues [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:1069#5294 [AACR2002-5294 15 KB]
Soleas G, Grass L, Josephy PD, Diamandis EP, Goldberg DM.
The anticarcinogenic effects of red win polyphenols in a mouse skin model [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2002;43:1145#5675 [AACR2002-5675 11 KB]
Bjartell A, Paju A, Stenman UH, Vaisanen V, Aumuller G, Diamandis E, Becker C, Lilja H.
Studies on phenotypic expression patterns of proteases and protease inhibitors in benign compared to malignant prostate tissues [abstract]
American Association for Cancer Research
Prostate Cancer and Prostatic Diseases 2002;3:#S7 [AACR2002-S7 108 KB]
Katsaros D, Fracchioli S, Yousef GM, Luo L-Y, Scorilas A, Puopolo M, Stenman U-H, van der Zee AGJ, Vergote I, Diamandis EP.
Human kallikrein 6 (hK6) and 10 (hK10): New potential biomarkers for diagnosis and prognosis of epithelial ovarian cancer [abstract]
American Society of Clinical Oncology
Proceedings of the American Society of Clinical Oncology 2002;21:#817 [ASCO2002-0817 47 KB]
Luo LY, Katsaros D, Scorilas A, Diamandis EP.
Serum human kallikrein 10: A novel marker for diagnosis and prognosis of ovarian cancer [abstract]
Canadian Laboratory Medicine Congress
Proceedings of the Canadian Laboratory Medicine Congress 2002;54#P2-05 [Abs252 103 KB]
Yousef GM, Kyriakopoulou LG, Fracchioli S, Zarghooni M, Scorilas A, Diamandis M, Katsaros D, Diamandis EP.
A new potential independent prognostic marker for ovarian cancer [abstract]
Canadian Laboratory Medicine Congress
Proceedings of the Canadian Laboratory Medicine Congress 2002;54#P2-06 [Abs253 157 KB]
Kyriakopoulou LG, Scorilas A, Yousef GM, Ponzone R, Roagna R, Sismondi P, Diamandis EP.
Human kallikrein 7 (KLK7) as a prognostic marker in breast cancer [abstract]
Canadian Laboratory Medicine Congress
Proceedings of the Canadian Laboratory Medicine Congress 2002;55#P2-07 [Abs254 100 KB]
Diamandis EP.
Genomic and proteomic technologies and their relevance to Clinical diagnostics [abstract]
Canadian Laboratory Medicine Congress
Proceedings of the Canadian Laboratory Medicine Congress 2002;31#W204 [Abs255 132 KB]
Diamandis EP, Magklara A, Yousef GM, Obiezu CV, Chang A, Sidiropoulos M.
Towards identification of new prostatic biomarkers [abstract]
Clinical Ligand Assay Society
Journal of Clinical Ligand Assay 2002;25:118 [CLAS2002A 117 KB]
Diamandis EP, Luo L-Y, Yousef GM, Bunting P, Soosaipillai A, Grass L.
Two new ovarian cancer biomarkers [abstract]
Clinical Ligand Assay Society
Journal of Clinical Ligand Assay 2002;25:118 [CLAS2002-A 128 KB]
Diamandis EP, Luo L-Y, Yousef GM, Bunting P, Soosaipillai A, Grass L.
Two new ovarian cancer biomarkers [abstract]
Clinical Ligand Assay Society
Journal of Clinical Ligand Assay 2002;25:118 [CLAS2002B 139 KB]
Diamandis EP, Magklara A, Yousef GM, Obiezu CV, Chang A, Sidiropoulos M.
Towards identification of new prostatic biomarkers [abstract]
Clinical Ligand Assay Society
Journal of Clinical Ligand Assay 2002;25:118 [CLAS2002-B 139 KB]

2001

Brauer PM, Mckeown-Eyssen G, Jazmaji V, Logan AG, Andrews DF, Jenkins DJ, Marcon N, Saibil F, Cohen L, Stern H, Baron D, Greenberg G, Diamandis E, Kakis G, Singer W, Steiner G.
Familial aggregation of diabetes, hypertension and cardiovascular conditions in colorectal hyperplastic polyps [abstract]
American Journal of Epidemiology 2001 Jun 1;153(11):S117 [ISI 000169006400389 64 KB]
Brauer PM, Mckeown-Eyssen G, Jazmaji V, Logan AG, Andrews DF, Jenkins DJ, Marcon N, Saibil F, Cohen L, Stern H, Baron D, Greenberg G, Diamandis E, Kakis G, Singer W, Steiner G.
Familial aggregation of prostate cancer in colorectal neoplasia [abstract]
American Journal of Epidemiology 2001 Jun 1;153(11):S117 [ISI 000169006400391 62 KB]
Yousef GM, Diamandis EP.
Cloning of seven novel human kallikrein genes: new potential cancer biomarkers [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2001 Jun;47(6):A130 [ISI 000168996400545 88 KB]
Yousef GM, Kyriakopoulou L, Scorilas A, Ponzone R, Giai M, Sismondi P, Diamandis EP, Rendel L, Diamandis M.
A novel potential prognostic marker for breast carcinoma [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2001 Jun;47(6):A130 [ISI 000168996400546 78 KB]
Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M, Fracchioli S, Diamandis EP.
A novel prognostic marker in ovarian cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 2001 Jun;47(6):A132 [ISI 000168996400553 62 KB]
Yousef GM, Scorilas A, Kyriakopoulou LG, Rendel L, Diamandis M, Ponzone R, Diamandis EP.
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer [abstract]
Canadian Breast Cancer Research Initiative 2001 May 3;195 [Abs219]
Nam R, Narod SA, Trachtenberg J, Magklara A, Diamandis EP.
Use of human kallikrein-2 (hK2) levels in patient selection for prostate biopsy [abstract]
Journal of Urology 2001;165:204#845 [Abs220 121 KB]
Sauter ER, Chervoneva I, Diamandis A, Khosravi J, Litwin S, Diamandis EP.
NAF biomarkers predict premenopausal and serum biomarkers predict postmenopausal breast cancer risk [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:11#59 [Abs204 164 KB]
Hoffman BR, Katsaros D, Scorilas A, Diamandis P, Fracchioli S, Rigault de la Longrais IA, Diamandis EP.
Tumour specific activity of kallikrein 6 protein is a prognostic marker of ovarian carcinoma [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:46-47#243 [Abs205 150 KB]
Luo L-Y, Bunting P, Diamandis EP.
The KLK10 gene (also known as the normal epithelial cell-specific 1 gene; NES1): A new serum biomarker for ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:47#244 [Abs206 97 KB]
Luo L-Y, Soosaipillai, Diamandis EP.
Identification of immunoreactive antigens in ovarian and breast carcinoma [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:156-7#838 [Abs207 104 KB]
Bharaj B, Scorilas A, Giai M, Diamandis EP.
Dinucleotide repeat length polymorphism on the 3' untranslated region of the SRD5A2 gene in breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:495-6#2668 [Abs208 122 KB]
Luo L-Y, Diamandis EP.
Protein array analysis with laser-excited solid-phase time-resolved fluorometry [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:564#3030 [Abs209 98 KB]
Scorilas A, Katsaros D, Kwamie A, Fracchioli S, Diamandis EP.
The SR-A1 gene, encoding a new member of the human Ser/Arg-Rich family of pre-mRNA splicing factors, is overexpressed in aggressive ovarian Tumours and is an independent unfavourable prognostic indicator in ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:579#3106 [Abs210 113 KB]
Luo L-Y, Katsaros D, Scorilas A, Fracchioli S, Massobrio M, Diamandis EP.
Human kallikrein 1- (hK10, normal epithelial cell-specific 1, NES1) is a new prognostic biomarker for ovarian carcinoma [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:579#3107 [Abs211 118 KB]
Luo L-Y, Soosaipillai A, Jung K, Diamandis EP.
Molecular cloning of a novel gene which appears to be down-regulated in testicular cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:748#4016 [Abs212 94 KB]
ousef GM, Scorilas A, Jung K, Ashworth L, Diamandis EP.
Molecular cloning of a new human kallikrein gene, KLK15, which is up-regulated in prostate cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:748#4017 [Abs213 83 KB]
Magklara A, Scorilas A, Katsaros D, Fracchioli S, Rigault de la Longrais I, Piccinno R, Yousef GM, Diamandis EP.
The prognostic value of human KLK8 (neuropsin/ovasin) in ovarian cancer and evidence for alternative splicing [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:781#4194 [Abs214 115 KB]
Obiezu CV, Jung K, Katsaros D, Diamandis EP.
Expression of a new splice variant of prostase/KLK4 is associated with tissues regulated by steroids [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:781-2#4196 [Abs215 96 KB]
Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP.
Down-regulation of a novel human kallikrein gene, KLK14, in endocrine related cancers [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:782#4198 [Abs216 103 KB]
Diamandis EP, Yousef G, Soosaipillai A, Bunting P.
Zyme/protease M/neurosin (KLK5 gene): A new biomarker for ovarian cancer diagnosis and monitoring [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:782#4200 [Abs217 109 KB]
Rosenberg Zand RS, Jenkins DJA, Diamandis EP.
Steroid hormone effects of natural products and nutraceuticals [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2001;42:870#4667 [Abs218 89 KB]
Katsaros D, Fracchioli S, Genta F, Yousef GM, Diamandis EP.
First Evidence of Expression of the New Human Kallikrein Gene Family Members (KLK4, KLK5, hK6) in Epithelial Ovarian Cancer: Genomic Organization, Molecular Characterization and Clinical Implications [abstract]
American Society of Clinical Oncology
Proceedings of the American Society of Clinical Oncology 2001;20:#839 [ASCO2001-0839 46 KB]
Diamandis EP, Petraki C, Karavana VN, Skoufoggiannis PT, Little S, Howarth DJ, Yousef GM.
Immunohistochemical localization of a new serine protease, human kallikrein 6, in the islets of Langerhan's and other endocrine organs [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2001;206#P1-266 [Abs221 113 KB]
Magklara A, Brown TJ, Diamandis EP.
Characterization of androgen receptor and co-factor expression in human breast cancer cell lines [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2001;570#P3-573 [Abs222 131 KB]
Kollara A, Rosenberg Zand RS, Diamandis EP, Brown TJ.
Characterization of androgen-dependent prostate specific antigen (PSA) secretion in androgen receptor-transfected human prostate cancer PC-3 cells [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2001;592#P3-676 [Abs223 119 KB]

2000

Black MH, Diamandis EP.
Serum total and free prostate-specific antigen for breast cancer diagnosis in women [abstract]
Department of Defense Breast Cancer Research Program 2000 Jun;49#J-5 [Hope2000-J5 17 KB]
Yousef GM, Diamandis EP.
Characterization of the human kallikrein gene locus and discovery of six new genes [abstract]
Canadian Society of Clinical Chemists
Clinical Chemistry 2000 Jun;46(6):A170 [ISI 000087725600659 78 KB]
Jenkins DJ, Kendall CW, Jackson CJ, Garsetti M, Rosenberg-Zand RS, Agarwal S, Rao AV, Diamandis EP, Parker T, Faulkner D, Vuksan V, Vidgen E.
Effect of soy protein foods on LDL oxidation and ex vivo sex hormone receptor activity [abstract]
Federation of American Societies for Experimental Biology
FASEB Journal 2000 Mar 15;14(4):A495 [ISI 000085918102864 50 KB]
Diamandis EP.
Kallikreins as cancer biomarkers [abstract]
Clinical Biochemistry Reviews 2000;21:107 [Abs203 129 KB]
Magklara A, Scorilas A, Catalona WJ, Diamandis EP.
Human glandular kallikrein (hK2) and prostate specific antigen (PSA) in prostate and breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;41:39#248 [Abs178 86 KB]
Katsaros D, Yu H, Francchioli S, Richiardi G, Danese S, Genta F, Levesque MA, Khosravi JM, Papanastasiou-Diamandi A, Gordini G, Diamandis EP, Massobrio M.
Insulin-like growth factor binding protein-3 (IGFBP-3) is associated with favorable glinicopathological features and survival in patients with epithelial ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;41:501#3195 [Abs180 77 KB]
Sauter ER, Litwin S, Engstrom F. Diamandis A, Khosravi J, Diamandis EP.
Fragmented insulin-like growth factor binding protein type-3 is inversely associated with breast cancer risk [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;41:575#3661 [Abs181 62 KB]
Obiezu CV, Yousef GM, Katsaros D, Diamandis EP.
Prostase/KLK-L1 is overexpressed in ovarian Tumours [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;41:684#4348 [Abs182 72 KB]
Yousef GM, Foussias G, Magklara A, Grass L, Diamandis EP.
Cloning of KLK-L5, a new member of the kallikrein gene family and its hormonal regulation in breast cancer cell lines [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;41:747#4748 [Abs183 122 KB]
Scorilas A, Bharaj B, Hoffman B, Giai M, Diamandis EP.
The genotypes of the 5?-reductase gene are related with PSA expression and risk in sporadic breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;41:805#5116 [Abs185 87 KB]
Rosenberg-Zand R, Jenkins DJ, Diamandis EP.
Antagonist steroid hormone activity of flavonoids and related compounds in an in vivo tissue culture system [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;41:847#5377 [Abs186 78 KB]
Hoffman BR, Scorilas A, Diamandis EP, Giai M, Levesque MA, Bharaj B.
A prevalent polymorphism in the proximal androgen response element of the prostate specific antigen gene and its implications in breast cancer prognosis [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;(41):93#596 [AACR2000-0596]
Chang A, Yousef GM, Diamandis EP.
Discovery of a new human kallikrein-like gene, KLK-L4, and the study of its expression in breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 2000;41:747#4749 [AACR2000-4749 19 KB]
Luo LY, Diamandis EP.
Down-regulation of the normal epithelial cell-specific 1 (NES1) gene is associated with unfavorable outcome of prostate cancer [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 2000;33:233#24 [Abs188 132 KB]
Obiezu CV, Scorilas A, Kim H, Diamandis EP.
Prostase/KLK-L1 is differentially expressed in normal/benign versus malignant ovarian tissues [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 2000;33:234#27 [Abs189 100 KB]
Rosenberg Zand RS, Jenkins DJA, Diamandis EP.
Anti-androgen activity of flavonoids [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 2000;33:238#40 [Abs190 111 KB]
Scorilas A, Kyriakopoulou L, Diamandis EP.
Cloning of a human gene, encoding a member of the SER/ARG-rich family of proteins that interact with RNA POL-II [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 2000;33:239#42 [Abs191 137 KB]
Soleas G, Grass L, Josephy D and Diamandis EP.
Resveratrol, a red wine constituent, anticarcinogenic properties [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 2000;33:240#44 [Abs192 107 KB]
Yousef GM and Diamandis EP.
The new human kallikrein gene family on chromosome 19q13.3-q13.4 and associations to various tumours [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 2000;33:242#51 [Abs193 150 KB]
Kim H, Yousef GM, Katsaros D, Diamandis EP.
Dramatic overexpression of the kallikrein-like gene 2 (KLK-L2), in ovarian carcinomas [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 2000;33:230#16 [CSCC2000-16 51 KB]
Diamandis EP, Magklara A, Scorilas A, Catalona WJ.
Prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2): Two hormonally regulated kallikreins with application in breast and prostate cancer [abstract]
International Congress of Endocrinology (ICE)
International Congress of Endocrinology Proceedings 2000;#P819 [Abs202 200 KB]
Scorilas A, Kyriakopoulou LG, Yousef GM, Diamandis EP.
Molecular characterization of a human homolog of the rat A1 gene [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2000;112#437 [Endo2000-0437 21 KB]
Chang A, Yousef GM, Magklara A, Diamandis EP.
Hormonal regulation of a novel kallikrein-like gene, KLK-L4, in breast cancer [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2000;117#461 [Endo2000-0461 21 KB]
Yousef GM, Magklara A, Diamandis EP.
KLK-L5 is a new, hormonally regulated member of the kallikrein gene family [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2000;188#765 [Endo2000-0765 24 KB]
Rosenberg Zand RS, Diamandis EP, Stanczyk FZ.
Hermaphrodiol may contribute significantly to the estrogenic/androgenic hormonal milieu of breast and prostate cancer cells [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2000;190#773 [Endo2000-0773 27 KB]
Diamandis EP, Nicar MR, Shi R, Berkel HJ, Nam R, Trachtenberg J, Yu H.
Changes in serum insulin-like growth factor binging protein-2 (IGFBP-2) and prostate cancer recurrence [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2000;493#2036 [Endo2000-2036 29 KB]
Magklara A, Cheung CC, Asa SL, Diamandis EP.
Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 2000;591#2442 [Endo2000-2442 21 KB]

1999

Goodwin PJ, Ennis M, Madarnas Y, Pritchard KI, Trudeau ME, Hood N, Diamandis EP.
Fasting insulin as a potential mediator of the adverse prognostic effect of obesity in locoregional breast cancer [abstract]
22nd Annual San Antonio Breast Cancer Symposium
1999 Dec 8 [Abs166 269 KB]
Scorilas A, Bharaj B, Giai M, Diamandis EP.
Polymorphisms in the human 5 alpha-reductase gene and breast cancer [abstract]
Clinical Cancer Research 1999 Nov;5:3826S [ISI 000083945700478 95 KB]
Yousef GM, Luo LY, Black MH, Diamandis EP.
Molecular characterization, mapping, tissue expression and hormonal regulation of KLK-L2, a new member of the kallikrein gene family [abstract]
Clinical Cancer Research 1999 Nov;5:3826S [ISI 000083945700479 40 KB]
Magklara A, Scorilas A, Catalona WJ, Diamandis EP.
The ratio of human glandular kallikrein (hK2) to free PSA improves the discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately elevated total PSA levels [abstract]
Clinical Cancer Research 1999 Nov;5:3826S [ISI 000083945700480 112 KB]
Yousef GM, Obiezu CO, Luo LY, Black MH, Diamandis EP.
The new kallikrein-like gene, Prostase/KLK-L1, is expressed in prostate and breast tissues and is hormonally regulated [abstract]
Clinical Cancer Research 1999 Nov;5:3827S [ISI 000083945700481 78 KB]
Bharaj B, Scorilas A, Hoffman B, Giai M, Diamandis EP.
A novel ARE-1 polymorphism in the promoter region of the prostate specific antigen gene in healthy females and women with breast cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1999 Jun;45(6):A37 [ISI 000080676500235 119 KB]
Levesque MA, D'costa M, Diamandis EP.
ELISA-determined p21(WAF1) expression does not correlate with non-small cell lung cancer aggressiveness [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1999 Jun;45(6):A111 [ISI 000080676500511 83 KB]
Scorilas A, Diamandi A, Khosravi MJ, Levesque MA, Lopez-Otin C, De Los Toyos J, Sampedro A, Giai M, Ponzone R, Roagna R, Sismondi P, Diamandis EP.
Determination of pepsinogen C concentration in breast tumor cytosols by a highly sensitive immunofluorometric assay and its association with ether prognostic variables [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1999 Jun;45(6):A117 [ISI 000080676500535 108 KB]
Arnett WP, Zini A, Jarvi K, Diamandis EP.
Prostaglandin D synthase in human semen: a marker to differentiate obstructive from non-obstructive [abstract]
Journal of Urology 1999;161:280#1084 [Abs158 164 KB]
Diamandis EP.
Tumour markers in prostate cancer [abstract]
Clinical Chemistry and Laboratory Medicine 1999;37:S33 [Abs161 235 KB]
Zarghami NZ, Diamandis EP, Grass L.
PSA mRNA expression during menstrual cycle is upregulated by progesterone [abstract]
Clinical Chemistry and Laboratory Medicine 1999;37:S159#M172 [Abs162 169 KB]
Lianidou ES, Politis I, Angelopoulou K, Diamandis EP.
A simple SSCP protocol for mutational analysis of p53 gene, optimized and evaluated in respect to DNA sequencing [abstract]
Clinical Chemistry and Laboratory Medicine 1999;37:S229#T050 [Abs163 199 KB]
Soleas GJ, Angelini M, Diamandis EP, Goldbert DM.
The absorption of trans-resveratrol in the rat [abstract]
Canadian Journal of Cardiology 1999;15:210D [Abs170 185 KB]
Soleas GJ, Diamandis EP, Goldberg DM, Grass L.
Do alcoholic beverages prevent the development of atherosclerosis in the rabbit? [abstract]
Canadian Journal of Cardiology 1999;15:210D [Abs171 165 KB]
Scorilas A, Bharaj B, Giai M, Diamandis EP.
Polymorphisms in the human 5-alpha-reductase gene and breast cancer [abstract]
AACR-NCI-EORTC International Conference 1999
Proceedings 1999;98#481 [Abs172 125 KB]
Yousef GM, Luo LY, Diamandis EP, Sotiropoulou G, Herbrick J-A, Scherer SW, Grass L.
The zyme/protease M/neurosin gene maps close to the human kallikrein gene family and is hormonally regulated [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:34#230 [Abs148 110 KB]
Scorilas A, Diamandis EP, Levesque MA, Diamandi A, Khosravi MJ, Giai M, Ponzone R, Roagna R, Sismondi P, Lopez-Otin C.
Pepsinogen C, an independent favorable prognostic factor in node-positive breast cancer patients [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:205#1359 [Abs149 144 KB]
Obiezu CV, Black MH, Magklara A, Levesque MA, Sutherland DJA, Tindall DJ, Young CFY, Sauter ER, Diamandis EP.
Expression of a prostate-associated protein, human glandular kallikrein (hK2) in breast Tumours and in normal breast secretion [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:378#2505 [Abs150 166 KB]
Yu H, Bharaj B, Giai M, Diamandis EP.
CAG repeats of the androgen receptor gene in breast cancer and its association with survival [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:380#2518 [Abs151 108 KB]
Luo LY, Grass L, Diamandis EP.
The expression of the normal epithelial cell-specific 1 (NES1) gene is regulated by steroid hormones [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:381#2521 [Abs152 145 KB]
Vassilikos EJK, Yu H, Trachtenberg J, Nam R, Narod S, Diamandis EP.
How many prostate cancer patients are considered �cured� after radical prostatectomy? [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:381#2524 [Abs153 158 KB]
Levesque MA, Yu H, Genta F, Massobrio M, Durando A, Bellino R, Diamandis EP, Katsaros D.
Expression of p53 but not WAF1 is a predictor of response to platinum-based chemotherapy in patients with epithelial ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:382#2531 [Abs154 134 KB]
Bharaj B, Vassilikos E, Diamandis EP.
Rapid and accurate determination of CAG repeat lengths in androgen receptor gene using PCR and automated fragment analysis [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:468#3094 [Abs155 129 KB]
Angelopoulou K, Borchert G, Lianidou E, Lilja H, Diamandis EP.
Characterization of a BRCA1-like compound present in human seminal plasma [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:685#4519 [Abs156 151 KB]
Magklara A, Black MH, Obiezu CV, Melegos DN, Diamandis EP.
Development of an ultrasensitive immunoassay for human glandular kallikrein (hK2) with no cross reactivity with prostate specific antigen [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1999;40:526#3467 [Abs157 118 KB]
Katsaros D, Levesque MA, Genta F, Durando A, Bellino R, Mano MP, Aidala S, Diamandis EP, Massobrio M.
Dose-Response Effect Between P53 Concentrations, Survival and Responsiveness in Patients with Epithelial Ovarian Cancer Treated with Platinum-Based Chemotherapy [abstract]
American Society of Clinical Oncology
Proceedings of the American Society of Clinical Oncology 1999;18:#1454 [ASCO1999-1454 46 KB]
Diamandis EP.
Application of ultrasensitive, third-generation prostate specific antigen assays in breast and prostate cancer [abstract]
Clinical Ligand Assay Society
Journal of Clinical Ligand Assay 1999;22:385 [CLAS1999-A 39 KB]
Diamandis EP, Angelopoulou K.
p53 antibodies [abstract]
Clinical Ligand Assay Society
Journal of Clinical Ligand Assay 1999;22:385 [CLAS1999-B 40 KB]
Yousef GM, Luo L-Y, Diamandis EP.
The human kallikrein gene locus � discovery of six new genes [abstract]
International Federation of Clinical Chemistry and Laboratory Medicine
IFCC-WorldLab Symposium II 1999;21#14 [Abs159 191 KB]
Scorilas A, Diamandis EP, Levesque MA, Diamandi A, Koshravi MJ, Giai MJ, Ponzone R, Roagna R, Sismondi P, Lopez-Otin C.
Prognostic value of pepsinogen C in breast cancer [abstract]
International Federation of Clinical Chemistry and Laboratory Medicine
IFCC-WorldLab Symposium II 1999;25#18 [Abs160 209 KB]
Obiezu CV, Giltay EJ, Yu H, Magklara A, Soosaipillai AR, Gooren LJG, Diamandis EP.
Serum prostate specific antigen is significantly elevated after testosterone administration in female to male transsexuals [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 1999;(102):#OR29-4 [Abs164 160 KB]
Obiezu CV, Giltay EJ, Yu H, Magklara A, Gooren LJ, Diamandis EP.
Dramatic suppression of serum prostate specific antigen and human glandular kallikrein by anti-androgens in male to female transsexuals [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 1999;521#P3-382 [Abs165 161 KB]

1998

Reddy PP, Bagli DJ, Diamandis EP, Melegos DN, Barrieras D, Merguerian P, Mclorie GA, Khoury AE.
Prostate specific antigen in the study of dysfunctional voiding [abstract]
Pediatrics 1998 Sep;102(3):839 [ISI 000075810500381 121 KB]
Klijn JGM, Diamandis EP, Yu H, Look MP, Gelder MEMV, Van Putten WLJ, Foekens JA.
The significance of prostate specific antigen (PSA) in breast cancer [abstract]
European Journal of Cancer 1998 Sep;34:S106 [ISI 000076886700440 71 KB]
Melegos DN, Grass L, Pierratos A, Diamandis EP.
Serum prostaglandin D synthase concentration is elevated in humans with renal impairment [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1998 Jun;44:A20 [ISI 000074065700079 93 KB]
Levesque MA, D'costa M, Spratt EH, Yaman MM, Diamandis EP.
Prognostic significance of quantitatively-analyzed p53 protein accumulation in lung carcinoma [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1998 Jun;44:A42 [ISI 000074065700186 82 KB]
Diamandis EP, Angelopoulou K, Zarghami N, Herbrick J, Scherer S.
Mapping of a novel 5 kb sequence on human chromosome 5 [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1998 Jun;44:A43 [ISI 000074065700191 67 KB]
Angelopoulou K, Borchert G, Melegos D, Lianidou E, Lilja H, Diamandis EP.
BRCA1-specific antibodies react strongly with a protein present in seminal plasma [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1998 Jun;44:A43 [ISI 000074065700192 85 KB]
Borchert GH, Giai M, Ponzone R, Roagna R, Sgro L, Diamandis EP, Sismondi P.
Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases [abstract]
European Journal of Cancer 1998 May;34:S3 [ISI 000074334200010 69 KB]
Katsaros D, Genta F, Durando A, Danese S, Ricchiardi R, Levesque M, Diamandis EP, Massobrio M.
p53 and WAF1 expression in epithelial ovarian cancer: Prognostic and predictive implications [abstract]
European Journal of Cancer 1998 May;34:S22 [ISI 000074334200109 66 KB]
Luo L, Diamandis EP.
Amplification of human genome DNA sequences with polymerase chain reaction using a single oligonucleotide primer [abstract]
Oak Ridge Conference
Proceedings of the Oak Ridge Conference 1998 Apr [Abs139]
Levesque MA, Lianidou ES, Angelopoulou K, Yu H, Genta F, Durando A, Massobrio M, Bharaj B, Diamandis EP.
Mutational analysis versus ELISA for the detection of p53 gene abnormalities in ovarian carcinoma [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:230-1 [Abs126 86 KB]
Sauter ER, Ehya H, Babb J, Diamandis EP, Daly M, Klein-Szanto AJP, Sigurdson E, Hoffman J, Malick J, Engstrom PF.
Nipple aspirate fluid (NAF) cytology predicts residual disease after diagnostic biopsy [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:228 [Abs128 151 KB]
Yu H, Levesque MA, Khosravi MJ, Diamandis EP, Clark GM.
Insulin-like growth factor binding protein 3 and breast cancer recurrence [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:232 [Abs129 135 KB]
Sauter ER, Daly MB, Engstrom PF, Melegos DN, Diamandis A, Khosravi MJ, Diamandis EP.
IGFBP-3 expression in nipple aspirate fluid (NAF) correlates with breast cancer risk [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:233 [Abs130 136 KB]
Majumdar S, Diamandis EP.
Mutations in the regulatory region of the prostate specific antigen gene from breast Tumours and cell lines [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:248 [Abs131 189 KB]
Angelopoulou K, Yu H, Diamandis EP.
Mutational spectrum of the p53 gene, Tumour p53 protein overexpression and serum p53 autoantibody generation in patients with breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:547 [Abs132 183 KB]
Bharaj B, Angelopoulou K, Diamandis EP.
Rapid sequencing of the p53 gene with the MicroGene Blaster automated DNA sequencer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:547 [Abs133 176 KB]
Black MH, Giai M, Yu H, Diamandis EP.
Serum prostate specific antigen levels are elevated in females with breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:553 [Abs135 181 KB]
Melegos DN, Diamandis EP, Helle SI, Yu H, Lundgren S, Lonning PE.
Plasma prostate specific antigen levels and prognostic value in patients with metastatic breast cancer following megestrol acetate treatment [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:553 [Abs136 207 KB]
Diamandis EP, Kogan I, Prody C, Angelopoulou K, Zarghami N, Herbrick J, Scherer S.
Cloning of a novel nucleotide sequence from human lung tissue [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:133 [Abs137 187 KB]
Luo LY, Herbrick J, Scherer S, Diamandis EP.
Mapping the normal epithelial cell-specific 1 gene to chromosome 19q13 [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;39:133 [Abs138 186 KB]
Katsaros D, Levesque M, Genta F, Durando A, Arisio R, Yu H, Diamandis EP, Massobrio M.
Prognostic and predictive implications of p53 and WAF1 expression in ovarian cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;(39):231 [AACR1998-231]
Klijin JGM, Diamandis EP, Yu H, Look MP, Meijer-van Gelder ME, van Putten WLJ, Foekens JA.
Expression of prostate specific antigen correlates with poor response to tamoxifen therapy in recurrent breast cancer [abstract]
American Association for Cancer Research
Proceedings of the American Association for Cancer Research 1998;(39):553 [AACR1998-553]
Katsaros D, Genta F, Durando A, Danese S, Ricchiardi R, Levesque M, Diamandis EP, Massobrio M.
PROGNOSTIC AND PREDICTIVE VALUE OF p53 AND WAF1 EXPRESSION IN EPITHELIAL OVARIAN CANCER [abstract]
American Society of Clinical Oncology
Proceedings of the American Society of Clinical Oncology 1998;17:#1355 [ASCO1998-1355 46 KB]
Angelopoulou K, Diamandis EP, Zargharmi N, Herbrick J, Scherer S.
Cloning of a new gene that is overexpressed in lung cancer cell lines [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1998;31:299 [Abs140 249 KB]
Luo L, Grass, Diamandis EP.
The normal epithelial cell-specific gene 1 (NES1) resides on chromosome 19q13 and its expression is regulated by steroid hormones [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1998;31:299 [Abs141 269 KB]
Luo L, Grass L, Diamandis EP.
The normal epithelial cell-specific gene 1 (NES1) resides on chromosome 19q13 and its expression is regulated by steroid hormones [abstract]
The Endocrine Society
Proceedings of The Endocrine Society 1998;P3-153 [Abs142 165 KB]

1997

Soleas GJ, Diamandis EP, Tomlinson G, Goldberg DM.
Identifying the major phenolic antioxidants of wine [abstract]
Atherosclerosis 1997 Oct;134(1 to 2):207 [ISI A1997XY10600949 140 KB]
Giai M, Ponzone R, Roagna R, Sgro L, Biglia N, Borchert GH, Diamandis EP, Sismondi P.
Subfractions of prostate specific antigen differ in serum of normal women and women with malignant and benign breast diseases [abstract]
Breast 1997 Oct;6(5):P919 [ISI A1997YJ70400087 105 KB]
Melegos DN, Freedman MS, Diamandis EP.
Prostaglandin D synthase in cerebrospinal fluid and serum from patients with various neuropathologies [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997 Jun;43:360 [ISI A1997XD36300359 83 KB]
Melegos DN, Freedman MS, Diamandis EP.
Prostate specific antigen immunoreactivity in cerebrospinal fluid [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997 Jun;43:361 [ISI A1997XD36300360 83 KB]
Black MH, Diamandis EP, Grass CL.
Ultrasensitive immunofluorometric assay for measuring free prostate specific antigen [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997 Jun;43:541 [ISI A1997XD36300540 92 KB]
Levesque MA, Yu H, Clark GM, Diamandis EP.
ELISA-detected p53 protein accumulation is a prognostic factor in a large cohort of breast cancer patients [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997 Jun;43:566 [ISI A1997XD36300565 99 KB]
Zarghami N, Levesque MA, Dcosta M, Angelopoulou K, Diamandis EP.
Frequency of prostate specific antigen mRNA expression in lung tumors [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997 Jun;43:582 [ISI A1997XD36300581 83 KB]
Angelopoulou K, Yu H, Diamandis EP.
p53 autoantibodies in sera of breast cancer patients: Association with p53 gene mutations and p53 protein overexpression [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997 Jun;43:770 [ISI A1997XD36300769 92 KB]
Lianidou ES, Angelopoulou D, Diamandis EP.
Identification of deletions and insertions in the p53 gene in ovarian tumors by high resolution fragment analysis and DNA sequencing [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997 Jun;43:771 [ISI A1997XD36300770 72 KB]
Diamandis EP.
Prostate specific antigen: A Tumour marker for prostatic and breast carcinoma [abstract]
Balkan J Clin Lab 1997;4:25 [Abs124]
Goldberg DM, Diamandis EP.
The beneficial health effects of wine drinking � a myth or a reality? [abstract]
Balkan J Clin Lab 1997;4:41 [Abs125]
Kogan I, Ballinger JR, Diamandis EP, Melegos DN, Rauth AM.
Prostate specific antigen induction by a steroid hormone in T47D cells growing in SCID mice [abstract]
American Association for Cancer Research
Cancer Research 1997;38:58#387 [AACR1997-0387 58 KB]
Sauter E, Zarghami N, Diamandis EP, Engstrom P.
PSA levels in nipple aspirate fluid are upregulated by progesterone [abstract]
American Association for Cancer Research
Cancer Research 1997;38:263#1767 [AACR1997-1767 90 KB]
Angelopoulou K, Katsaros D, Diamandis EP.
The exon 5 of p53 Tumour suppressor gene is a target for deletions in ovarian cancer [abstract]
American Association for Cancer Research
Cancer Research 1997;38:270#1815 [AACR1997-1815 85 KB]
Levesque MA, Yu H, Clark GM, Diamandis EP.
P53 protein accumulation detected by an ELISA technique is a prognostic factor in a large cohort of breast cancer patients [abstract]
American Association for Cancer Research
Cancer Research 1997;(38):255 [AACR1997-255]
Yu H, Levesque MA, Clark GM, Diamandis EP.
Prognostic value of PSA in breast cancer. A large U.S. cohort study [abstract]
American Association for Cancer Research
Cancer Research 1997;38:437#2924 [AACR1997-2924 79 KB]
Levesque MA, Yu H, Clark GM, Diamandis EP.
ELISA-detected p53 protein in accumulation is a prognostic factor in a large cohort of breast cancer patients [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997;43:S228 [Abs119 123 KB]
Majumdar S, Diamandis EP.
The prostate specific antigen (PSA) gene is not mutated in either breast Tumours or breast carcinoma cell lines [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1997;43:S268 [Abs121 104 KB]
Majumdar S, Diamandis EP.
Structural characterization of the prostate specific antigen gene from breast Tumours and cell lines [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1997;30:381 [Abs115 128 KB]
Diamandis EP, Zarghami N, Grass L, Sauter E.
Prostate specific antigen levels in serum during the menstrual cycle. Possible regulation by progesterone [abstract]
The Endocrine Society
Proceedings of the 79th Annual Meeting 1997;385 [Abs114 75 KB]

1996

Zarghami N, Diamandis EP.
Concordance between prostate specific antigen mRNA expression and protein in breast tumors [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996 Jun;42(6):440 [ISI A1996UR52200441 74 KB]
Angelopoulou K, Diamandis EP, Dunn JM, Jia Q.
Fragment analysis of the p53 gene: Method development and clinical applications [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996 Jun;42(6):443 [ISI A1996UR52200444 88 KB]
Zarghami N, Grass L, Diamandis EP.
Regulation of the prostate specific antigen gene in breast cancer cell lines by steroid hormones [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996 Jun;42(6):586 [ISI A1996UR52200586 77 KB]
Melegos DN, Yu H, Diamandis EP.
Prostaglandin D2 synthase in amniotic fluid: Possible association with fetal abnormalities [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996 Jun;42(6):593 [ISI A1996UR52200593 60 KB]
Melegos DN, Diamandis EP.
Diagnostic value of molecular forms of prostate specific antigen for female breast cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996 Jun;42(6):594 [ISI A1996UR52200594 73 KB]
Dcosta M, Levesque M, Tadross L, Diamandis E.
Comparison of immunofluorometry and immunohistochemistry for the detection of p53 protein in lung cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996 Jun;42(6):694 [ISI A1996UR52200694 78 KB]
Levesque M, Dcosta M, Diamandis E.
P53 protein is absent from the serum of patients with lung cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996 Jun;42(6):695 [ISI A1996UR52200695 63 KB]
Yu H, Levesque MA, Khosravi MJ, Papanastasioudiamandis A, Clark GM, Diamandis EP.
Associations between PSA and IGF-I, IGF-II, IGFBP-1, and IGFBP-3 in breast cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996 Jun;42(6):703 [ISI A1996UR52200703 76 KB]
Rosenberg RS, Diamandis EP, Kendall CWC, Ransom TPP, Jenkins DJA.
The effect of plant derived compounds on sex hormone receptors: Implications for hormone-dependent cancer development and treatment [abstract]
Federation of American Societies for Experimental Biology
FASEB Journal 1996 Mar 8;10(3):2833 [ISI A1996TZ28402831 49 KB]
Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP.
IGF-1, IGF-11, IGFBP-1 and IGFBP-3 as prognostic markers of breast cancer [abstract]
Proceedings of the 10th International Congress of Endocrinology 1996;2:756 [Abs100 80 KB]
Diamandis EP.
Prostaglandin D2 synthase in amniotic fluid and maternal serum: possible association with fetal abnormalities [abstract]
Prostaglandins 1996;51:297 [Abs101 176 KB]
Diamandis EP, Melegos DN, Oda H, Urade Y, Hayaishi O.
Prostaglandin D Synthase: Development of analytical methodology and preliminary clinical studies [abstract]
Prostaglandins Leukotrienes and Essential Fatty Acids 1996;55:57 [Abs108 98 KB]
Sauter ER, Daly M, Linahan K, Ehay H, Engstrom PF, Sorling A, Bonney G, Ross E, Yu H, Diamandis EP.
Prostate specific antigen levels in nipple aspirate fluid correlate with breast cancer risk [abstract]
American Association for Cancer Research
Cancer Research 1996;37:213#1458 [AACR1996-1458 65 KB]
Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP.
No associations between IGFBP-3 and p53 or PSA in breast cancer [abstract]
American Association for Cancer Research
Cancer Research 1996;37:189 [AACR1996-189]
Yu H, Levesque MA, Khosravi MJ,Papanastasiou-Diamandi A, Clark GM, Diamandis EP.
Associations between PSA and IGF-1, IGF-11, IGFBP-3 in breast cancer [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1996;42:264 [Abs104 81 KB]

1995

Galvan B, Christopoulos TK, Diamandis EP.
DESIGN OF A TIME-RESOLVED FLUOROMETRIC HYBRIDIZATION ASSAY FOR THE MESSENGER-RNA OF PROSTATE-SPECIFIC ANTIGEN [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Nov;41(11):42 [ISI A1995TD49700073 76 KB]
Melegos DN, He Y, Allen LC, Diamandis EP.
PROSTATE-SPECIFIC ANTIGEN IN AMNIOTIC-FLUID AND MATERNAL SERUM -POSSIBLE ASSOCIATIONS WITH FETAL ABNORMALITIES [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S39 [ISI A1995RD90400026 80 KB]
Yu H, Diamandis EP.
IDENTIFICATION OF PROSTATE-SPECIFIC ANTIGEN IN MILK OF LACTATING WOMEN [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S39 [ISI A1995RD90400027 72 KB]
Goldberg DM, Tham L, Diamandis EP, Karumanchiri A, Soleas GJ.
THE ASSAY OF RESVERATROL AND ITS DISTRIBUTION IN HUMAN BLOOD [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S115 [ISI A1995RD90400365 98 KB]
Angelopoulou K, Stratis M, Diamandis EP.
HUMORAL IMMUNE-RESPONSE AGAINST P53 TUMOR-SUPPRESSOR GENE-PRODUCT IN WOMEN WITH OVARIAN-CANCER [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S218 [ISI A1995RD90400810 78 KB]
Zarghami N, Giai M, Yu H, Katsaros D, Diamandis EP.
CREATINE-KINASE BB ISOENZYME LEVELS IN TUMOR CYTOSOLS AND SURVIVAL OF BREAST-CANCER PATIENTS [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S218 [ISI A1995RD90400814 77 KB]
Yu H, Diamandis EP, Levesque M, Asa S, Monne M, Croce CM.
EXPRESSION OF THE PROSTATE-SPECIFIC ANTIGEN GENE IN A PRIMARY OVARIAN-CARCINOMA [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S219 [ISI A1995RD90400815 76 KB]
Levesque MA, Diamandis EP, Yu H, Zola P, Sismondi P, Giardina G, Katsaros D.
IMMUNOFLUOROMETRICALLY QUANTIFIED P53 PROTEIN AS A PROGNOSTIC INDICATOR IN OVARIAN-CARCINOMA [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S224 [ISI A1995RD90400838 84 KB]
Diamandis EP, Levesque MA, Clark GM.
QUANTITATIVE-ANALYSIS OF MUTANT P53 PROTEIN IN BREAST-CARCINOMA -RELATIONSHIPS TO OTHER PROGNOSTIC FACTORS [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S224 [ISI A1995RD90400839 87 KB]
Randell EW, Yu H, Diamandis EP, Ellis G.
PROSTATE-SPECIFIC ANTIGEN IN NEONATES AND INFANTS [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1995 Jun;41(6):S230 [ISI A1995RD90400865 77 KB]
Diamandis EP.
Tumour suppressor genes and oncogenes in cancer: Are the present techniques meeting the challenge? [abstract]
European Journal of Clinical Chemistry and Clinical Biochemistry 1995;33:A121 [Abs79 164 KB]
Yu H, Diamandis EP, Sutherland DJA.
Immunoreactive prostate specific antigen in breast cancer cytosols and its association with steroid hormone receptors [abstract]
American Association for Cancer Research
Cancer Research 1995;36:245#1463 [AACR1995-1463 63 KB]
Yu H, Diamandis EP.
Prostate specific antigen (PSA) as a new prognostic marker in female breast cancer: molecular characterization and clinical implication [abstract]
American Association for Cancer Research
Cancer Research 1995;36:246#1464 [AACR1995-1464 57 KB]
Monne M, Croce CM, Yu H, Diamandis EP.
Molecular characterization of prostate specific antigen mRNA expressed in breast Tumours [abstract]
American Association for Cancer Research
Cancer Research 1995;36:249#1484 [AACR1995-1484 63 KB]
Tham L, Goldberg DM, Diamandis EP, Karumanchiri A, Soleas GJ.
Extraction of resveratrol from human blood [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:339#58 [CSCC1995-58 113 KB]
Angelopoulou KA, Stratis M, Diamandis EP.
Serum p53 autoantibodies: Incidence in ovarian carcinoma [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:340#61 [CSCC1995-61 128 KB]
Levesque MA, Clark GM, Diamandis EP.
Relationships between mutant p53 protein overexpression and other prognostic indicators in breast cancer [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:340#62 [CSCC1995-62 128 KB]
Levesque MA, Diamandis EP, Yu H, Zola P, Sismondi P, Giardina G, Katsaros D.
Prognostic value of immunofluorometrically quantified p53 protein in ovarian carcinoma [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:340#63 [CSCC1995-63 128 KB]
Zarghami N, Giai M, Yu H, Katsaros D, Diamandis EP.
Association between breast cancer patient survival and levels of creatine kinase BB in Tumour cytosols [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:341#64 [CSCC1995-64 136 KB]
Yu H, Diamandis EP, Levesque MA, Asa S, Monne M, Croce CM.
Prostate specific antigen gene expression in ovarian cancer post-liver transplantation [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:341#65 [CSCC1995-65 136 KB]
Yu H, Diamandis EP.
The milk of lactating women contains prostate specific antigen [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:341#66 [CSCC1995-66 136 KB]
Melegos DN, Yu H, Allen LC, Diamandis EP.
A possible association between fetal abnormalities and levels of prostate specific antigen in amniotic fluid [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:341#67 [CSCC1995-67 136 KB]
Hoffman BR, Yu H, Diamandis EP.
Prostate cancer screening using prostate specific antigen extracted from dried blood on filter paper [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1995;28:342#68 [CSCC1995-68 141 KB]
Melegos DN, Yu H, Allen LC, Diamandis EP.
Prostate specific antigen in amniotic fluid and maternal serum [abstract]
Clinical Ligand Assay Society
Journal of Clinical Ligand Assay 1995;(18):66 [CLAS1995]

1994

Yu H , Diamandis EP, Giai M, Ponzone R, Sismondi P, Katsaros D.
Evaluation of prostate specific antigen as a prognostic and predictive indicator for breast cancer patients [abstract]
European Journal of Cancer 1994;30A:548 [Abs74 65 KB]
Goldberg D, Garovic-Kocic V, Diamandis EP, Pace-Asciak CR, Roncari DAK.
Resveratrol and ethanol are mediators of changes in plasma lipids and lipoproteins [abstract]
Atherosclerosis 1994;109:77 [Abs75 88 KB]
Katsaros D, Zola P, Sismondi P, Levesque M, Diamandis EP.
Prognostic value of p53protein accumulation in ovarian carcinomas [abstract]
American Association for Cancer Research
Cancer Research 1994;35:234#1399 [AACR1994-1399 67 KB]
Angelopoulou K, Diamandis EP, Bunting PS.
Colorectal carcinoma elicits a humoral immune response against p53 mutant protein [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1994;27:201 [Abs68 111 KB]
Goldberg DM, Garovic-Kocic V, Diamandis EP, Pace-Asciak CR.
Is resveratrol the solution to the French paradox? [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1994;27:226 [Abs69 115 KB]
Zarghami N , Grass L, Sutherland DJA, Diamandis EP.
Creatine kinase isoenzyme BB is associated with the estrogen receptor in breast cancer [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1994;27:231 [Abs70 114 KB]
Diamandis EP, He Y, Grass L.
Androgens, progestins and tamoxifen induce PSA production in the breast cancer cell line T-47D [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1994;27:232 [Abs71 109 KB]
Yu H, Diamandis EP, Sutherland DJA.
Detection of prostate specific antigen in breast Tumours [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1994;27:232 [Abs72 90 KB]
Levesque M, Diamandis EP, He Y, Sutherland DJA.
Quantitative analysis of prostate specific antigen and mutant p53 protein in breast Tumour cytosols: Relationships with other prognostic indicators [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1994;27:232 [Abs73 119 KB]

1993

Goldberg DM, Karumanchiri A, Eng E, Diamandis EP, Yan J, Soleas GJ, Waterhouse AL.
Resveratrol content of wines assayed by a direct gas chromatographic-mass spectrometric technique [abstract]
American Journal of Enology and Viticulture 1993;44:344 [Abs65 139 KB]
Soleas GJ, Goldberg DM, Diamandis EP, Karumanchiri A, Ng E, Yan J.
A gas chromatographic-mass spectrometric method for the analysis of resveratrol in juice and wine samples [abstract]
American Journal of Enology and Viticulture 1993;44:344 [Abs66 111 KB]
Goldberg DM, Yan J, Ng E, Diamandis EP, Karumanchiri A, Waterhouse AL, Soleas GJ.
A definitive gas-chromatographic mass-spectrometric assay for resveratrol suitable for industrial and biological samples [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1993;26:126-27 [Abs58 187 KB]
Angelopoulou K, Diamandis EP, Kellen J, Bunting P, Sutherland D.
Prevalence of antibodies against p53 protein in various cancers [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1993;26:128-29 [Abs59 100 KB]
Angelopoulou K, Diamandis EP.
New methodology for measuring anti-p53 antibodies in human serum [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1993;26:129 [Abs60 114 KB]
Chan A, Krajden M, Diamandis EP.
Quantification polymerase chain reaction analysis of pathogenic DNA sequence using an internal DNA sequence standard constructed by recombinant DNA methodology [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1993;26:136-37 [Abs61 144 KB]
Chan A, Jiu Z, Krajden M, Diamandis EP.
Quantitative analysis of polymerase chain reaction products with high performance liquid chromatography and fluorometric detection [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1993;26:137 [Abs62 121 KB]
Morton RC, Papanastasiou-Diamandi A, Diamandis EP, Khosravi MJ.
Time-resolved enzyme immunoassay for the determination of thyrotropin in serum [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1993;26:139 [Abs63 99 KB]
Papanastasiou-Diamandi A, Morton RC, Diamandis EP, Khosravi MJ.
A highly sensitive alpha-fetoprotein (AFP) immunoassay based on enzymatically amplified time-resolved fluorometry [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1993;26:140 [Abs64 112 KB]

1992

Diamandis EP, Christopoulos TL. Bean CC.
Sensitive and quantitative analysis of Western blots by using time-resolved immunofluorometry [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1992;38:987 [Abs55 95 KB]
Hassapoglidou S, Diamandis EP.
Non-isotopic detection techniques for Southern blot analysis of single-copy genes [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1992;38:991 [Abs56 77 KB]
Diamandis EP, Grass LC, Uldall R, Mendelsohnn D, Maini D.
Mannitol in serum of hemodialysis patients measured by fluorometry and mannitol dehydrogenase from Leuconostoc mesenderoides [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1992;38:984 [Abs57 91 KB]
Hassapoglidou S, Diamandis EP.
The p53 suppressor gene product quantified in cell lines, Tumour tissue and biological fluids using an ultrasensitive time-resolved fluorescence immunoassay [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1992;25:135 [Abs52 114 KB]
Chan A, Krajden M, Diamandis EP.
Direct and indirect quantification of polymerase chain reaction products with a time-resolved fluorometric scanner [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1992;25:137 [Abs53 123 KB]
Papanastasiou-Diamandi A, Khosravi MJ, Morton RC, Diamandis EP.
Total thyroxine immunoassay based enzymatically amplified time-resolved fluorometry [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1992;25:#148 [Abs54 105 KB]

1991

Diamandis EP, Kitching R, Christopoulos TK.
Enzyme amplified time-resolved fluoroimmunoassays [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1991;37:1038 [Abs50 87 KB]
Christopoulos TK, Diamandis EP.
Applications of time-resolved fluorometry in molecular biology techniques [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1991;37:1060 [Abs51 90 KB]

1990

Christopoulos TK, Lianidou ES, Diamandis EP.
ULTRASENSITIVE ANALYTICAL METHODOLOGIES USING TIME-RESOLVED FLUOROMETRY AND LASER-EXCITED SOLID-PHASE MEASUREMENTS [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1990 Jun;36(6):1094 [ISI A1990DJ43600739 59 KB]
Lianidou ES, Christopoulos TK, Diamandis EP.
CREATINE-KINASE ISOENZYME MB QUANTIFICATION IN SERUM WITH TIME-RESOLVED IMMUNOFLUOROMETRY [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1990 Jun;36(6):1130 [ISI A1990DJ43600903 82 KB]
Wong T, Mclaurin J, Makela SK, Diamandis EP, Ellis G.
DEVELOPMENT OF A TIME-RESOLVED FLUORESCENCE IMMUNOASSAY FOR 17-ALPHA-HYDROXYPROGESTERONE [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1990 Jun;36(6):1150 [ISI A1990DJ43600999 57 KB]
Breborowicz A, Rodela H, Pagiantzis J, Diamandis EP, Oreopoulos DG.
Glucose toxicity to human mesothelial cells in vitro [abstract]
10th Annual Conference on Peritoneal Dialysis
Proceedings of the 10th Annual Conference on Peritoneal Dialysis 1990 Feb [Abs45]
Breborowicz A, Rodela H, Pagiantzis J, Diamandis EP, Oreopoulos DG.
Mesothelial cells produce a growth promoting factor [abstract]
10th Annual Conference on Peritoneal Dialysis
Proceedings of the 10th Annual Conference on Peritoneal Dialysis 1990 Feb [Abs46]

1989

Bhayana V, Diamandis EP.
A SOLID-PHASE TIME-RESOLVED IMMUNOFLUOROMETRIC ASSAY FOR CARCINOEMBRYONIC ANTIGEN (CEA) [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1989 Jun;35(6):1077 [ISI A1989AB73800123 52 KB]
Diamandis EP, Papanastasioudiamandi A, Lustig V, Khosravi MJ, Tan A.
A TIME-RESOLVED IMMUNOFLUOROMETRIC ASSAY OF HUMAN PANCREATIC AMYLASE IN SERUM [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1989 Jun;35(6):1117 [ISI A1989AB73800305 47 KB]
Khosravi MJ, Diamandis EP.
TIME-RESOLVED IMMUNOFLUOROMETRY OF FOLLITROPIN IN SERUM [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1989 Jun;35(6):1138 [ISI A1989AB73800407 53 KB]
Reichstein E, Diamandis EP.
IMMUNOASSAY OF NEONATAL HTSH IN PAPER DISKS USING TIME-RESOLVED FLUORESCENCE [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1989 Jun;35(6):1139 [ISI A1989AB73800408 50 KB]
Tan A, Khosravi MJ, Diamandis EP.
TIME-RESOLVED IMMUNOFLUOROMETRIC ASSAY FOR THYROXINE-BINDING GLOBULIN IN SERUM [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1989 Jun;35(6):1139 [ISI A1989AB73800409 53 KB]
Shankaran P, Reichstein E, Diamandis EP.
IMMUNOASSAYS FOR RUBELLA ANTIBODIES (IGG AND IGM) IN SERUM USING TIME-RESOLVED FLUORESCENCE [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1989 Jun;35(6):1153 [ISI A1989AB73800474 53 KB]
McLaurin J, Makela SK, Diamandis EP, Ellis G.
Evaluation of the CyberFluor time-resolved fluorescence immunoassay for human growth hormone in the diagnosis of growth hormone deficiency [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1989;22:260 [Abs41 64 KB]
Papanastasiou-Diamandi A, Morton RC, Khosravi MJ, Diamandis EP.
New assay configurations for competitive-type time-resolved fluoroimmunoassays of haptens [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1989;22:260-1 [Abs42 78 KB]
Morton RC, Diamandis EP.
A streptavidin based macromolecular complex labeled with a europium chelator as a universal detection system in time-resolved fluorescence immunoassay [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1989;22:261 [Abs43 80 KB]

1988

Diamandis EP, Evangelista RA, Pollak A, Templeton EF, Lowden JA.
A NEW GENERATION OF TIME-RESOLVED FLUOROIMMUNOASSAYS WITH EUROPIUM CHELATES AS LABELS [abstract]
Journal of Bioluminescence and Chemiluminescence 1988 Oct-Dec;2(4):200 [ISI A1988P830900055 107 KB]
Diamandis EP, Morton RC.
PROTEIN LABELING WITH THE FLUORESCENT-PROBE, 4,7-BIS(CHLOROSULFOPHENYL)-1,10-PHENANTHROLINE-2,9-DICARBOXYLIC ACID (BCPDA), PROCEDURES AND APPLICATIONS IN IMMUNOASSAYS [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1155 [ISI A1988N930400041 59 KB]
Diamandis EP, Evangelista RA, Pollak A, Templeton EF, Lowden JA.
TIME-RESOLVED FLUOROIMMUNOASSAYS WITH EUROPIUM CHELATES AS LABELS - A NEW GENERATION OF ALTERNATIVE IMMUNOASSAYS [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1155 [ISI A1988N930400042 60 KB]
Diamandis EP, Morton RC, Reichstein E, Khosravi MJ.
MULTIPLE FLUORESCENT LABELING OF STREPTAVIDIN FOR HIGHLY SENSITIVE TIME RESOLVED IMMUNOASSAYS [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1157 [ISI A1988N930400049 63 KB]
Papanastasioudiamandi A, Bhayana V, Diamandis EP.
A NON-ISOTOPIC TOTAL THYROXINE IMMUNOASSAY WITH TIME-RESOLVED FLUORESCENCE AND A MONOCLONAL-ANTIBODY [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1210 [ISI A1988N930400308 50 KB]
Reichstein E, Morton RC, Diamandis E.
A SENSITIVE ASSAY FOR TSH WITH TIME-RESOLVED FLUORESCENCE AND MONOCLONAL-ANTIBODIES [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1216 [ISI A1988N930400334 49 KB]
Diamandis EP, Bhayana V, Conway K, Reichstein E, Papanastasioudiamandi A.
A TIME-RESOLVED FLUOROIMMUNOASSAY OF CORTISOL IN SERUM - A RAPID NON-ISOTOPIC ASSAY [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1216 [ISI A1988N930400337 53 KB]
Khosravi MJ, Diamandis EP.
A SENSITIVE IMMUNOASSAY FOR CHORIO-GONADOTROPIN (HCG) BY TIME-RESOLVED FLUORESCENCE SPECTROSCOPY, WITH A NEW EUROPIUM CHELATE AS LABEL [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1220 [ISI A1988N930400352 57 KB]
Khosravi MJ, Diamandis EP.
TIME-RESOLVED IMMUNOFLUOROMETRY OF LUTROPIN - A HIGHLY SENSITIVE AND RAPID PROCEDURE [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1221 [ISI A1988N930400361 80 KB]
Kahan I, Papanastasioudiamandi A, Dcosta M, Diamandis E.
A TIME-RESOLVED IMMUNOFLUOROMETRIC ASSAY FOR THE MEASUREMENT OF PROLACTIN IN SERUM [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1226 [ISI A1988N930400382 55 KB]
Khosravi MJ, Chan MA, Bellem AC, Diamandis EP.
A SENSITIVE TIME-RESOLVED IMMUNOFLUOROMETRIC ASSAY OF FERRITIN IN SERUM WITH MONOCLONAL-ANTIBODIES [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1988 Jun;34(6):1275 [ISI A1988N930400619 50 KB]
Yiannakou L, Diamandis EP, Souvatzoglou A.
Extraction, immunoprecipitation and calculation of the cross-reactivity and concentration of digoxin-like immunoreactive substances (DLIS) in cord blood plasma [abstract]
8th International Congress of Endocrinology
Proceedings of the 8th International Congress of Endocrinology 1988 [Abs25 128 KB]

1987

Chan MA, Bellem AC, Diamandis EP.
A TIME-RESOLVED FLUOROIMUNOASSAY FOR ALPHA-FETOPROTEIN IN SERUM AND AMNIOTIC-FLUID [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1987 Aug;20(4):285 [ISI A1987K397700022 104 KB]
Diamandis EP, Reichstein E, Ramjeesingh M.
LABELING STRATEGIES IN TIME-RESOLVED FLUOROIMMUNOASSAYS AND IMMUNOFLUOROMETRIC ASSAYS [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1987 Aug;20(4):285 [ISI A1987K397700023 91 KB]
Chan MA, Bellem AC, Diamandis EP.
A TIME-RESOLVED FLUOROIMMUNOASSAY FOR FERRITIN IN SERUM [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1987 Aug;20(4):294 [ISI A1987K397700048 108 KB]
Diamandis EP, Reichstein E, Conway K.
CORTISOL ASSAY IN SERUM WITH COMPETITIVE IMMUNOASSAY AND TIME-RESOLVED FLUORESCENCE SPECTROSCOPY [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1987 Aug;20(4):294 [ISI A1987K397700049 100 KB]
Khosravi MJ, Diamandis EP.
DETERMINATION OF HUMAN CHORIONIC-GONADOTROPIN BY A TIME-RESOLVED IMMUNOFLUOROMETRIC ASSAY [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1987 Aug;20(4):294 [ISI A1987K397700050 115 KB]
Chan MA, Diamandis E.
A TIME-RESOLVED FLUOROIMMUNOASSAY FOR THE DETERMINATION OF ALPHA-FETOPROTEIN IN SERUM [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1987 Jun;33(6):919 [ISI A1987H746400220 47 KB]
Yiannakou L, Diamandis EP, Souvatzoglou A.
Effect of steroid hormones on the assessment of the level of digoxin like immunoreactive substances [abstract]
The Greek Endocrinology Society
Proceedings of the 14th Panhellenic Conference 1987 [Abs24 148 KB]

1986

Mitsana-Papazoglou A, Christopoulos TK, Diamandis EP, Koupparis MA.
Ion-selective electrodes for the direct monitoring of the release of the active ingredients in dissolution studies of drugs. Automation with a continuous-flow system [abstract]
11th Panhellenic Chemistry Conference
Proceedings of the 11th Panhellenic Chemistry Conference 1986 Dec [Abs16 1.1 MB]
Christopoulos TK, Diamandis EP.
Application of ion-selective electrodes for the study of the binding of ions to albumin [abstract]
Panhellenic Chemistry Society
Proceedings of the 11th Conference 1986 Dec [Abs14 249 KB]
Christopoulos TK, Diamandis EP.
New types of ion-selective electrodes for continuous-flow clinical analysis [abstract]
Panhellenic Chemistry Society
Proceedings of the 11th Conference 1986 Dec [Abs15 166 KB]
Diamandis EP, Yannakou L, Souvatzoglou A.
EXTRACTION PURIFICATION AND CHARACTERIZATION OF DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES (DLIS) FROM CORD BLOOD-PLASMA [abstract]
AACC & CSCC
Clinical Chemistry 1986 Jun;32(6):1080 [ISI A1986C741900183 63 KB]
Yiannakou L, Diamandis EP, Souvatzoglou A.
Assay of catecholamines in urine and serum with high performance liquid chromatography and electrochemical detection [abstract]
Greek Endocrinology Society
Proceedings of the 13th Panhellenic Conference 1986 Apr [Abs12 118 KB]
Yiannakou L, Diamandis EP, Souvatzoglou A.
Isolation and purification of digoxin like immunoreactive substances from cord blood serum [abstract]
The Greek Endocrinology Society
Proceedings of the 13th Panhellenic Conference 1986 Apr [Abs13 128 KB]

1985

Christopoulos TK, Diamandis EP.
ASSAY OF ALBUMIN IN SERUM BASED SPECIFIC ION-BINDING AND ION-SELECTIVE ELECTRODE POTENTIOMETRY [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1985;31(6):904 [ISI A1985AJT3600066 77 KB]
Christopoulos TK, Diamandis EP.
ASSAY OF ALBUMIN IN SERUM BASED ON SPECIFIC ION-BINDING AND ION-SELECTIVE ELECTRODE (ISE) POTENTIOMETRY [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1985;18(3):202 [ISI A1985AHL8900032 57 KB]
Papanastasioudiamandi A, Diamandis EP, Souvatzoglou A.
SOLID-STATE EXTRACTION OF DIGOXIN-LIKE SUBSTANCES FROM HUMAN-URINE [abstract]
Canadian Society of Clinical Chemists
Clinical Biochemistry 1985;18(3):202 [ISI A1985AHL8900033 68 KB]

1984

Papanastasioudiamandi A, Diamandis EP, Soldin SJ.
ENZYMATIC MEASUREMENT OF PRIMARY BILE-ACIDS IN SERUM WITH THE IL-MULTISTAT III FLUORESCENCE LIGHT-SCATTERING CENTRIFUGAL ANALYZER [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1984;30(6):971 [ISI A1984SV67200225 58 KB]
Ellis G, Diamandis EP, Giesbrecht E, Allen LC.
AN AUTOMATED HPLC METHOD FOR HEMOGLOBIN-A1C [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1984;30(6):978 [ISI A1984SV67200264 57 KB]
Diamandis EP, Dcosta M.
IMPROVED LIQUID-CHROMATOGRAPHIC DETERMINATION OF URINARY FREE CORTISOL AFTER SOLID-STATE EXTRACTION [abstract]
American Association for Clinical Chemistry
Clinical Chemistry 1984;30(6):1042 [ISI A1984SV67200594 55 KB]
Diamandis EP, Hoffman B, Pollard A.
Hemoglobin measurement in serum and gastric aspirates based on peroxidase activity, automated on the Technicon RA-1000 Random Access Analyzer [abstract]
International Federation of Clinical Chemistry and Laboratory Medicine
Revista Brasileira de Analises Clinicas 1984;16:127 [Abs9]

1983

Sarantonis E, Karayannis MI, Diamandis EP.
The TNBS-Ion electrode. Some applications in kinetic methods of analysis [abstract]
First International Symposium of Kinetics in Analytical Chemistry
Abstracts of the First International Symposium of Kinetics in Analytical Chemistry 1983 Sep;12 [Abs5 87 KB]

1982

Christopoulos TK, Diamandis EP, Hadjiioannou TP.
Semiautomatic potentiometric titrations of drugs with sodium tetraphenylborate and a tetraphenylborate ion-selective electrode [abstract]
1st Panhellenic Pharmaceutical Conference
Proceedings of the 1st Panhellenic Pharmaceutical Conference 1982 [Abs4 91 KB]

1980

Papastathopoulos DS, Diamandis EP, Hadjiioannou TP.
A new flow- through electrode unit for liquid membrane electrodes [abstract]
Proceedings of the 1st Balkan Chemistry Days 1980;159 [Abs3 147 KB]
Diamandis EP, Papastathopoulos DS. Hadjiioannou TP.
Automated serum albumin determination based on the reaction with picrate ions using a flow-through picrate ion-electrode [abstract]
1st Balkan Chemistry Days
Proceedings of the 1st Balkan Chemistry Days 1980;157 [Abs2 163 KB]

1978

Hadjiioannou TP, Koupparis MA, Diamandis EP.
New Chloramine-T and picrate ion-selective electrodes [abstract]
The Chemical Society
Proceedings of the Analytical Division 1978 Mar;78-80 [Abs1 310 KB]

401 of 445 publications (90.1%) successfully linked to Acrobat PDFs.
445 Conference Abstracts

PubMgr (Publications Manager) program by Dr. Irv Bromberg, Medic/OS Consultants, Toronto, Canada <email>